{"gene":"KCND3","run_date":"2026-06-10T01:55:23","timeline":{"discoveries":[{"year":1996,"finding":"Kv4.3 (KCND3) encodes a rapidly inactivating A-type K+ current with biophysical and pharmacological properties matching the native cardiac transient outward current (Ito) in canine ventricular myocytes, establishing Kv4.3 as the primary molecular correlate of Ito in canine and likely human heart.","method":"Heterologous expression in Xenopus oocytes and HEK cells, whole-cell patch clamp, in situ hybridization in canine, human, and rat heart","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct electrophysiological characterization in heterologous system plus native tissue correlation, replicated across multiple species","pmids":["8831489"],"is_preprint":false},{"year":1997,"finding":"A novel alternatively spliced variant of Kv4.3 with a 19-amino acid insertion in the C-terminal intracellular region was cloned from rat vas deferens; this longer isoform is the predominant form in rat heart and smooth muscle, whereas the previously reported shorter form predominates in brain.","method":"RT-PCR cloning from rat vas deferens, functional expression in HEK293 cells, whole-cell patch clamp","journal":"FEBS letters","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct cloning and functional expression with electrophysiological validation across multiple tissues","pmids":["9450548"],"is_preprint":false},{"year":1999,"finding":"Two human Kv4.3 isoforms (long and short, differing by a 19-amino acid sequence) were cloned and expressed; both produce A-type K+ currents in Xenopus oocytes, and the short isoform has its steady-state inactivation curve shifted ~10 mV positive relative to the long isoform, shifting the window current peak accordingly.","method":"RT-PCR cloning, heterologous expression in Xenopus oocytes, whole-cell patch clamp","journal":"Journal of neurophysiology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct functional comparison of two cloned isoforms with electrophysiology, single lab","pmids":["10200233"],"is_preprint":false},{"year":2000,"finding":"Kvβ2 subunits co-associate with Kv4.3 proteins in the brain (co-immunoprecipitation). Kvβ1 or Kvβ2 expression increases Kv4.3 current density and protein expression without affecting channel gating. This association requires the C-terminus but not the N-terminus of Kv4.3, indicating a novel interaction mode distinct from Kv1-family channels.","method":"Co-immunoprecipitation from rat brain, co-expression in HEK cells, whole-cell patch clamp, Western blot","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP from native tissue plus heterologous expression with mutagenesis (C-terminus deletion), two orthogonal methods","pmids":["11087728"],"is_preprint":false},{"year":2000,"finding":"In vivo adenoviral overexpression of Kv4.3 in guinea pig myocytes generates robust transient outward current that progressively depresses the plateau potential and abbreviates action potential duration (APD). Dominant-negative Kv4.3-W362F suppressed Ito in rat ventriculocytes, prolonged APD ~30%, and extended the QT interval, demonstrating that Ito plays a causal role in setting plateau potential and APD.","method":"In vivo intramyocardial adenoviral gene transfer, whole-cell patch clamp in isolated myocytes, surface ECG recording","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo gain- and loss-of-function with defined electrophysiological phenotypes, reciprocal approach using both overexpression and dominant-negative","pmids":["10772652"],"is_preprint":false},{"year":2000,"finding":"Nicotine potently blocks Kv4.3 channels (IC50 ~40 nM) via both tonic (40%) and use-dependent (60%) block. Single-channel analysis showed reduced conductance, open probability, and open time with increased closed time. Nicotine does not act through neurotransmitter receptors, indicating direct channel block.","method":"Whole-cell and single-channel patch clamp in Xenopus oocytes expressing Kv4.3, canine ventricular myocyte Ito recordings, pharmacological receptor antagonist experiments","journal":"Circulation","confidence":"High","confidence_rationale":"Tier 1 / Moderate — single-channel and whole-cell analysis with receptor-antagonist controls establishing direct mechanism, single lab with multiple orthogonal methods","pmids":["10973847"],"is_preprint":false},{"year":2001,"finding":"Angiotensin II (Ang II) downregulates Kv4.3 mRNA and protein by destabilizing the mRNA (accelerating degradation) without affecting transcription, whereas phenylephrine (PE) downregulates Kv4.3 by inhibiting promoter activity (transcriptional suppression), demonstrating two independent mechanisms for Kv4.3 downregulation in cardiac hypertrophy.","method":"RNase protection assays, immunoblot, mRNA turnover measurements, Kv4.3 5'-flanking region cloning and promoter-reporter assays in neonatal rat cardiac myocytes","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (mRNA stability, promoter-reporter) distinguishing two independent regulatory mechanisms, replicated in same study","pmids":["11249870"],"is_preprint":false},{"year":2002,"finding":"KChIP2 splice variants (KChIP2S, KChIP2T, and a previously described isoform) each increase Kv4.3 current density, slow inactivation in a Ca2+-dependent manner, and hasten recovery from inactivation in a splice-variant-specific fashion. KChIP2 expression is graded transmurally in human and canine left ventricle.","method":"Kinetic RT-PCR, Western blot, immunocytochemistry, whole-cell patch clamp with co-expression in heterologous cells","journal":"Circulation","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (biochemical + electrophysiology), single lab","pmids":["12135940"],"is_preprint":false},{"year":2002,"finding":"KChIP2 palmitoylation at N-terminal cysteines is required for efficient plasma membrane localization of Kv4.3 channels. Longer KChIP2 isoforms containing a 32-amino acid N-terminal peptide with palmitoylation sites produce larger increases in Kv4.3 protein level and current density; mutating these cysteines reduces membrane localization and current enhancement.","method":"Metabolic labeling for palmitoylation, mutagenesis of palmitoylation cysteines, confocal immunofluorescence, whole-cell patch clamp in heterologous cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — metabolic labeling demonstrating PTM, mutagenesis showing functional consequence, subcellular localization experiments, single lab with multiple orthogonal methods","pmids":["12006572"],"is_preprint":false},{"year":2002,"finding":"A structurally minimal KChIP2 isoform (KChIP2d, C-terminal 70 amino acids with one EF-hand) is sufficient to accelerate Kv4.3 recovery from inactivation and slow inactivation kinetics. The EF-hand modulates inactivation but not recovery; Ca2+-independent recovery effects map to a stretch of amino acids outside the EF-hand.","method":"Cloning of KChIP2d from ferret heart, co-expression with Kv4.3 in Xenopus oocytes, whole-cell patch clamp, mutagenesis of EF-hand","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — domain deletion and mutagenesis with electrophysiological readout, single lab with multiple constructs","pmids":["12433945"],"is_preprint":false},{"year":2002,"finding":"Kv4.3 exhibits C-type (outer pore collapse) inactivation: removal of external K+ accelerates inactivation and promotes cumulative inactivation by repetitive stimulation. This is consistent with K+ occupancy of a selectivity filter site that stabilizes the conducting state.","method":"Whole-cell voltage-clamp with varied external K+ concentrations and ion substitution experiments in HEK cells expressing Kv4.3","journal":"The Journal of membrane biology","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — single lab, rigorous in vitro analysis but single method approach","pmids":["12172648"],"is_preprint":false},{"year":2004,"finding":"CaMKII directly phosphorylates Kv4.3 at S550 in the C-terminal region, slowing inactivation and accelerating recovery from inactivation. The S550A mutation renders Kv4.3 insensitive to both CaMKII dialysis and CaMKII inhibitory peptide, identifying S550 as the functionally critical phosphorylation site.","method":"Whole-cell patch clamp with intrapipette delivery of autothiophosphorylated CaMKII or inhibitory peptides, site-directed mutagenesis of consensus CaMKII phosphorylation sites in Kv4.3","journal":"American journal of physiology. Cell physiology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — mutagenesis identifying specific phosphorylation site combined with pharmacological and biochemical manipulation, single lab with multiple orthogonal methods","pmids":["15456698"],"is_preprint":false},{"year":2004,"finding":"Angiotensin receptor type 1 (AT1R) forms a physical complex with Kv4.3: co-immunoprecipitation from canine ventricle and from HEK293 cells co-expressing AT1R, Kv4.3, and KChIP2. FRET demonstrates close spatial proximity. Ang II stimulation internalizes Kv4.3 together with AT1R and shifts activation voltage threshold of remaining surface Kv4.3 to more positive values.","method":"Co-immunoprecipitation from native canine ventricle and HEK293 cells, FRET with CFP/YFP-tagged proteins, live-cell confocal imaging, whole-cell patch clamp","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal co-IP in native tissue confirmed by FRET and functional electrophysiology, multiple orthogonal methods in one study","pmids":["15342638"],"is_preprint":false},{"year":2004,"finding":"KChIP2b and KChIP2d modulate Kv4.3 gating by accelerating recovery from inactivation (acting on closed-state inactivation transitions), slowing closed-state inactivation, and promoting open-state inactivation. Ca2+-dependent effects on inactivation are mediated through open-state (not closed-state) inactivation mechanisms.","method":"Kinetic analysis of macroscopic currents in Xenopus oocytes co-expressing Kv4.3 with KChIP2 isoforms, multi-state kinetic modeling","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — comprehensive kinetic analysis with model validation, two KChIP2 isoforms compared, single lab","pmids":["14724186"],"is_preprint":false},{"year":2004,"finding":"In vivo adenoviral Kv4.3 gene transfer in rats subjected to aortic stenosis increased Ito density, shortened APD50, and abrogated cardiac hypertrophy. This was associated with significant reductions in calcineurin and NFATc1 expression, linking Kv4.3-mediated Ito to the calcineurin/NFAT hypertrophic pathway.","method":"In vivo adenoviral gene transfer, whole-cell patch clamp, immunoblot for calcineurin and NFATc1, heart weight/body weight ratio, cellular capacitance measurements","journal":"Circulation","confidence":"High","confidence_rationale":"Tier 2 / Moderate — in vivo gain-of-function with defined molecular pathway (calcineurin/NFAT) linked to electrophysiological and hypertrophic phenotypes, single lab multiple methods","pmids":["15557376"],"is_preprint":false},{"year":2005,"finding":"DPPX (DPP6) co-expressed with Kv4.3 in CHO cells accelerates inactivation and recovery from inactivation; co-expression of DPPX together with KChIP2a and Kv4.3 produces current kinetics matching native human ventricular Ito. DPPX protein is detected in human but not rat ventricle by specific antibody, establishing it as an essential component of the native human cardiac Ito channel complex.","method":"Quantitative real-time RT-PCR, Western blot, co-expression in CHO cells, whole-cell patch clamp comparison to native human ventricular Ito","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — functional reconstitution in CHO cells with comparison to native current, protein-level validation in human tissue, single lab multiple methods","pmids":["15890703"],"is_preprint":false},{"year":2006,"finding":"Ang II activates AT1 receptors to destabilize Kv4.3 channel mRNA via the 3'UTR through NADPH oxidase-derived superoxide acting on the ASK1-p38 kinase pathway. Mechanical stretch also downregulates Kv4.3 3'UTR reporter activity requiring AT1 receptors and NADPH oxidase. The effect is specific: Kv4.2 and Kv1.5 3'-UTR sequences are insensitive to Ang II.","method":"3'UTR-reporter mRNA and activity assays in neonatal rat ventricular myocytes, dominant-negative rac, NADPH oxidase inhibitors, SOD/catalase overexpression, ASK1-p38 pathway inhibitors, stretch experiments","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal genetic and pharmacological tools defining the pathway, confirmed for both chemical and mechanical stimuli, single lab","pmids":["16556864"],"is_preprint":false},{"year":2006,"finding":"CaMKII co-immunoprecipitates with Kv4.3 channels in rat ventricular myocytes without requiring Ca2+ elevation (basal association), whereas CaMKII association with Kv4.2 requires Ca2+ increase. Inhibition of CaMKII specifically accelerates Kv4.3 inactivation. Kv4.3 thus serves as a molecular scaffold concentrating CaMKII at the membrane, allowing localized Ca2+-dependent regulation of associated Kv4.2 channels.","method":"Co-immunoprecipitation from rat ventricular myocytes, Western blot phosphorylation analysis, whole-cell patch clamp with CaMKII inhibitors in HEK cells transfected with Kv4.2 or Kv4.3","journal":"American journal of physiology. Heart and circulatory physiology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — reciprocal co-IP from native tissue plus electrophysiology, distinguishing Kv4.2 vs Kv4.3 CaMKII dependence with multiple methods","pmids":["16648177"],"is_preprint":false},{"year":2006,"finding":"DPP10, another dipeptidyl peptidase-related subunit, modulates Kv4.3 inactivation primarily by affecting closed-state inactivation and causing negative shifts in steady-state activation and inactivation. When co-expressed with both Kv4.3 and KChIP2b, the effects of DPP10 on steady-state properties are abolished, while closed-state inactivation differences remain, demonstrating that DPP10 and KChIP2b modulate distinct inactivation states.","method":"Heterologous co-expression in CHO or HEK cells, whole-cell patch clamp, comparison of Kv4.3 alone, Kv4.3+KChIP2b, Kv4.3+DPP10, and triple combinations; truncation mutant of DPP10","journal":"American journal of physiology. Cell physiology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — systematic co-expression with multiple subunit combinations and truncation mutant identifying transmembrane domain sufficiency, single lab","pmids":["16738002"],"is_preprint":false},{"year":2007,"finding":"Kv4.3 mediates A-type K+ currents underlying subthreshold membrane potential oscillations (MPOs) in hippocampal CA1 LM/RAD interneurons. siRNA knockdown of Kv4.3 selectively impaired A-type K+ currents and abolished MPOs in these specific interneuron subpopulations.","method":"siRNA knockdown, whole-cell patch clamp in hippocampal interneurons in acute slices, immunocytochemistry for Kv4.3","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Moderate — cell-specific siRNA knockdown with defined electrophysiological phenotype (loss of MPOs), single lab with immunocytochemistry confirmation","pmids":["17314290"],"is_preprint":false},{"year":2007,"finding":"Genetic deletion of Kv4.3 (KCND3-/-) in mice does not eliminate ventricular Ito,f: functional Ito,f channels are expressed at normal density in Kv4.3-/- myocytes with unchanged properties, indicating Kv4.3 is not required for mouse ventricular Ito,f channel generation (in contrast to Kv4.2).","method":"Targeted gene disruption (Kv4.3-/- mice), whole-cell voltage clamp, quantitative RT-PCR, Western blot","journal":"Journal of molecular and cellular cardiology","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean knockout with multiple validation methods (electrophysiology + biochemistry), negative finding well-controlled","pmids":["18045613"],"is_preprint":false},{"year":2008,"finding":"KChIP4a has a crystal structure (3.0 Å resolution) showing distinct N-terminal α-helices. Competitive binding of the Kv4.3 N-terminal peptide to the hydrophobic groove of KChIP4a core displaces the KChIP4a N-terminus; this released N-terminus serves as a slow inactivation gate for Kv4.3. The first N-terminal α-helix of KChIP4a (residues 1–34) is sufficient to confer slow inactivation when fused to N-terminally truncated Kv4.3.","method":"X-ray crystallography (3.0 Å), biochemical competition binding, electrophysiology with N-terminal peptide application and chimeric channel constructs","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structure combined with biochemical and electrophysiological validation of mechanism, single lab with multiple orthogonal methods","pmids":["19109250"],"is_preprint":false},{"year":2008,"finding":"AUF1 (ARE/poly-(U)-binding/degradation factor 1) is upregulated by Ang II through AT1R-NADPH oxidase-p38 MAPK signaling. Elevated AUF1 binds to an AU-rich element (ARE) in the Kv4.3 3'UTR, destabilizing the mRNA. AUF1 overexpression mimics the Ang II effect, AUF1 siRNA blocks it, and pull-down assays confirm increased AUF1 binding to the Kv4.3 ARE after Ang II treatment.","method":"3'UTR deletion and mutagenesis analysis, AUF1 overexpression and siRNA knockdown, RNA pull-down assays, reporter mRNA stability assays in neonatal rat ventricular myocytes","journal":"Journal of molecular and cellular cardiology","confidence":"High","confidence_rationale":"Tier 2 / Strong — ARE identified by mutagenesis, AUF1 confirmed as effector by both overexpression and knockdown, direct RNA-protein interaction by pull-down, single lab multiple orthogonal methods","pmids":["18789946"],"is_preprint":false},{"year":2009,"finding":"NRSF (neuron-restrictive silencer factor) binds directly to the NRSE in the Kv4.3 gene promoter after peripheral nerve injury, causing epigenetic silencing: ChIP assay shows increased NRSF binding and markedly reduced acetylation of histone H4 (but not H3) at the Kv4.3-NRSE in dorsal root ganglion. Antisense knockdown of NRSF blocks the injury-induced Kv4.3 downregulation.","method":"Chromatin immunoprecipitation (ChIP) for NRSF binding and histone acetylation, antisense NRSF knockdown in rat dorsal root ganglion after sciatic nerve injury, RT-PCR","journal":"Neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP identifies specific epigenetic mechanism plus knockdown confirms functional relevance, single lab two orthogonal methods","pmids":["20006971"],"is_preprint":false},{"year":2009,"finding":"KCNE2 co-expression with Kv4.3 reduces peak current density, slows inactivation, and causes a positive shift of steady-state inactivation, rendering Kv4.3 more similar to native cardiac Ito. KCNE2 variants M54T and I57T produce gain-of-function effects (increased current density, slowed inactivation, faster recovery) compared to wild-type KCNE2.","method":"Co-expression of Kv4.3 with KCNE2 WT or variants in heterologous cells, whole-cell patch clamp","journal":"Heart rhythm","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — single lab, single electrophysiological method comparing WT and variant subunit effects","pmids":["20042375"],"is_preprint":false},{"year":2009,"finding":"The S3b region of Kv4.3 (residues L275 and V276) constitutes the binding site for the gating modifier toxin HpTx2; alanine scanning shows that simultaneous mutation of L275A and V276A nearly eliminates toxin interaction. KChIP2b co-expression increases HpTx2 affinity for Kv4.3, attributed to KChIP2b-induced stabilization of the closed state.","method":"Alanine-scanning mutagenesis of Kv4.3 S3b, electrophysiological concentration-response analysis in Xenopus oocytes, KChIP2b co-expression","journal":"Molecular pharmacology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — systematic alanine scanning with functional readout identifying binding determinants, single lab","pmids":["19357248"],"is_preprint":false},{"year":2009,"finding":"PKC isoform-specific regulation: PKCα plays the central role in PKC-dependent downregulation of Kv4.3 current. PMA and conventional PKC activator TMX reduced Kv4.3 current; these effects were abolished by PKCα inhibition (HBDDE) or PKCα siRNA but not by PKCβ inhibition or siRNA. PKCα activator iripallidal mimicked the effect on Kv4.3.","method":"Xenopus oocyte two-electrode voltage clamp, PKC isoform-selective inhibitors/activators, siRNA knockdown of PKCα vs PKCβ, native rat cardiomyocyte patch clamp","journal":"Journal of molecular and cellular cardiology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — pharmacological and genetic (siRNA) approaches converge on PKCα, confirmed in native cardiomyocytes, single lab multiple methods","pmids":["21803046"],"is_preprint":false},{"year":2009,"finding":"Closed-state inactivation (CSI) of Kv4.3 is differentially regulated by PKC in the two splice isoforms. PMA (PKC activator) reduces CSI magnitude in Kv4.3-short but increases CSI in Kv4.3-long. This isoform-specific difference maps to T504, a PKC phosphorylation site unique to the long isoform; T504D mutation eliminates the PMA response.","method":"Xenopus oocyte expression, whole-cell voltage clamp, PMA and purified PKC application, site-directed mutagenesis of T504","journal":"American journal of physiology. Cell physiology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — mutagenesis identifying specific phosphorylation site with electrophysiological validation, single lab with multiple perturbation approaches","pmids":["19675305"],"is_preprint":false},{"year":2010,"finding":"A dynamic Kv4.3-CaMKII complex is present at the plasma membrane of cardiomyocytes (co-IP and FRET). CaMKII dissociation from this complex increases CaMKII autophosphorylation and L-type Ca2+ current facilitation. Kv4.3 overexpression reduces basal CaMKII autophosphorylation and eliminates Ca2+-induced CaMKII activation by binding to the calmodulin binding sites of CaMKII.","method":"Co-immunoprecipitation from cardiomyocytes, FRET (CFP/YFP), overexpression of Kv4.3, BAPTA vs EGTA Ca2+ chelation, whole-cell patch clamp for L-type Ca2+ current","journal":"European heart journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — co-IP confirmed by FRET, gain-of-function with mechanistic dissection (calmodulin binding site), multiple orthogonal methods, single lab","pmids":["21148163"],"is_preprint":false},{"year":2010,"finding":"Kv4.2 and Kv4.3, along with Kv1.4, encode distinct components of the macroscopic IA in mouse cortical pyramidal neurons. Genetic deletion of Kv4.2 and Kv4.3 (double knockout) reveals a residual Kv1.4-encoded component; Kv4.3 encodes the larger component in neurons lacking both Kv4.2 and Kv1.4, and deletion of individual subunits causes subunit-specific electrical remodeling.","method":"Single and double knockout mouse models (Kv4.2-/-, Kv4.3-/-, Kv4.2-/-/Kv4.3-/-), whole-cell patch clamp in cortical pyramidal neurons, 4-AP pharmacology","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic dissection with double knockout and pharmacology, replicated across multiple genotypes","pmids":["20371829"],"is_preprint":false},{"year":2011,"finding":"Nitric oxide (NO) inhibits Kv4.3 current (IC50 ~375 nM) through activation of adenylate cyclase → cAMP-dependent protein kinase (PKA) → serine-threonine phosphatase 2A signaling cascade. This inhibition prolongs the plateau of mouse atrial action potential.","method":"Whole-cell patch clamp in CHO cells expressing Kv4.3 and in isolated human atrial and mouse ventricular myocytes, NO donors, adenylate cyclase and PKA modulators, phosphatase inhibitors","journal":"Cardiovascular research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pathway identified using pharmacological tools in both heterologous cells and native myocytes, single lab","pmids":["18678642"],"is_preprint":false},{"year":2011,"finding":"KCND3 gain-of-function mutations L450F and G600R (found in Brugada syndrome patients) increase peak Ito current density by 146% and 50% respectively when co-expressed with KChIP2 in HEK293 cells, establishing a gain-of-function mechanism for these mutations in Brugada syndrome pathogenesis.","method":"Site-directed mutagenesis, co-expression with KChIP2 in HEK293 cells, whole-cell patch clamp, Luo-Rudy AP model simulation","journal":"Heart rhythm","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct electrophysiological characterization of engineered mutations with simulation validation, single lab multiple methods","pmids":["21349352"],"is_preprint":false},{"year":2012,"finding":"KCND3 mutations cause SCA19/22: p.F227del mutant Kv4.3 is retained in the cytoplasm (loss of plasma membrane localization) with absent A-type K+ channel conductance in patch clamp. p.G345V and p.T377M mutations also identified as pathogenic, confirming KCND3 as the SCA19/22 gene across multiple ethnic groups.","method":"Whole exome sequencing, Sanger sequencing, immunofluorescence localization in heterologous cells, whole-cell patch clamp","journal":"Annals of neurology","confidence":"High","confidence_rationale":"Tier 2 / Strong — loss-of-function established by both subcellular localization (ER retention) and electrophysiology, replicated across multiple mutations and ethnic families","pmids":["23280837"],"is_preprint":false},{"year":2012,"finding":"SCA19 (KCND3) mutations T352P, M373I, and S390N cause Kv4.3 retention in the endoplasmic reticulum and enhanced protein instability. KChIP2 rescues membrane localization and stability of two of three mutants but does not fully restore channel function. T352P Purkinje cells show intracellular Kv4.3 accumulation with reduced protein levels in autopsy material.","method":"Exome sequencing, HeLa cell ectopic expression, immunofluorescence, whole-cell patch clamp, SCA19 cerebellar autopsy immunohistochemistry, KChIP2 rescue co-expression","journal":"Annals of neurology","confidence":"High","confidence_rationale":"Tier 2 / Strong — human autopsy confirmation + in vitro electrophysiology + subcellular localization + KChIP2 rescue experiment, multiple orthogonal methods","pmids":["23280838"],"is_preprint":false},{"year":2013,"finding":"KCND3 gain-of-function mutation A545P in Kv4.3 (found in early-onset lone AF patient) increases peak current density and slows inactivation compared to WT, both in the absence and presence of KChIP2, constituting a gain-of-function associated with atrial fibrillation.","method":"Direct sequencing of KCND3 in AF patients, co-expression in CHO-K1 cells with or without KChIP2, whole-cell patch clamp","journal":"Cardiovascular research","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — single patient mutation characterized electrophysiologically, single lab single method","pmids":["23400760"],"is_preprint":false},{"year":2014,"finding":"SEMA3A (semaphorin 3A) is a naturally occurring protein inhibitor that selectively reduces Kv4.3 peak current density without altering cell surface expression. Co-immunoprecipitation and disruption of a hanatoxin-like binding domain on Kv4.3 indicate a direct protein-protein interaction. SEMA3A mutations found in Brugada syndrome disrupt SEMA3A's ability to inhibit Kv4.3, resulting in gain-of-function.","method":"Co-expression in HEK293 cells with whole-cell patch clamp, co-immunoprecipitation, disruption of putative toxin-binding domain on Kv4.3, SEMA3A perfusion, iPSC-cardiomyocyte assays","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (co-IP, domain disruption mutagenesis, iPSC-CMs, heterologous cell perfusion) establishing direct interaction and functional consequence","pmids":["24963029"],"is_preprint":false},{"year":2014,"finding":"NS5806 (Kv4.3 current activator) binds at a hydrophobic site on the C-terminus of KChIP3 in a Ca2+-dependent manner (Kd 2–5 µM in Ca2+-bound form). NS5806 increases affinity between KChIP3 and the N-terminus of Kv4.3 and decreases the dissociation rate. Tyr-174 and Phe-218 on KChIP3 are required for this enhancement.","method":"Fluorescence spectroscopy, isothermal calorimetry, docking simulations, mutagenesis of KChIP3 residues","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — direct biophysical binding measurements (ITC + fluorescence) with mutagenesis confirmation, single lab multiple orthogonal methods","pmids":["25228688"],"is_preprint":false},{"year":2015,"finding":"SCA19/22-mutant Kv4.3 subunits exert a dominant-negative effect on WT Kv4.3 trafficking and surface expression in the absence of KChIP2; KChIP2 can rescue this dominant-negative effect. All SCA19/22 mutants either suppress WT Kv4.3 current amplitude or alter channel gating in a dominant manner.","method":"Co-expression of mutant and WT Kv4.3 in heterologous cells, surface expression assays, whole-cell patch clamp, KChIP2 rescue co-expression","journal":"Cellular and molecular life sciences","confidence":"High","confidence_rationale":"Tier 2 / Moderate — dominant-negative mechanism demonstrated by co-expression with WT plus KChIP2 rescue, single lab multiple constructs","pmids":["25854634"],"is_preprint":false},{"year":2015,"finding":"A de novo KCND3 mutation (p.Arg293_Phe295dup) duplicating the RVF motif in the voltage-sensor domain causes a severe shift of voltage-dependence of gating to more depolarized voltages, demonstrating that addition of an extra positive charge to the S4 voltage sensor profoundly impairs Kv4.3 channel function.","method":"Whole exome sequencing, immunocytochemistry, immunoblot, whole-cell patch clamp","journal":"BMC medical genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — single de novo mutation with electrophysiological characterization, single lab, single patient","pmids":["26189493"],"is_preprint":false},{"year":2009,"finding":"Ang II acting via AT1R-ROS-p38 MAPK signaling downregulates Kv4.3 mRNA and protein expression and decreases A-type K+ current in CATH.a neurons. This mechanism contributes to Kv4.3 downregulation in the RVLM of chronic heart failure rats, leading to neuronal hyperexcitability and sympathoexcitation.","method":"Rat Genome GeneChip array, real-time RT-PCR, Western blot, whole-cell patch clamp in CATH.a cells, Tempol (superoxide scavenger) and SB-203580 (p38 inhibitor) pharmacology, RVLM microinjection of 4-AP","journal":"American journal of physiology. Heart and circulatory physiology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pathway confirmed by pharmacological inhibitors in neuronal cell line with in vivo correlation, single lab","pmids":["20044444"],"is_preprint":false},{"year":2009,"finding":"Thyroid hormone receptors TRα1 and TRβ1 divergently regulate KCND3 transcription: TRα1 activates and TRβ1 suppresses KCND3 promoter activity. Deletion and mutagenesis mapping identified the TRα1 response element at −1651 bp (G-1651T abolishes activation) and the TRβ1 response element at −73 bp (G-73T abolishes suppression) of the KCND3 transcription start site.","method":"Adenoviral overexpression of TRα1/TRβ1 in rat cardiomyocytes, KCND3 5'-flanking reporter constructs, deletion analysis, site-directed mutagenesis of TR binding sites, patch clamp","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — promoter-reporter analysis with deletion mapping and mutagenesis confirming specific TR binding sites, functional electrophysiology validation, single lab","pmids":["19171649"],"is_preprint":false},{"year":2012,"finding":"Large T-antigen increases Kv4.3 expression through upregulation of transcription factor Sp1; Sp1 decoy oligonucleotide reduces Kv4.3 expression in HEK-293T cells, and Sp1 overexpression increases Kv4.3 in HEK-293 cells. Inhibition of Kv4.3 (by 4-AP or siRNA) induces cell apoptosis and necrosis that is rescued by the CaMKII inhibitor KN-93, placing Kv4.3 upstream of CaMKII-mediated cell death.","method":"Sp1 decoy oligonucleotide, Sp1 overexpression vector, siRNA knockdown of Kv4.3, 4-AP pharmacology, cell viability/death assays, KN-93 rescue","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Sp1-dependent transcription confirmed by gain and loss of function; CaMKII-apoptosis link via pharmacological rescue, single lab","pmids":["22023388"],"is_preprint":false},{"year":2018,"finding":"Kv4.3 expression in nociceptive-like TG neurons is downregulated following infraorbital nerve chronic constrictive injury (ION-CCI), reducing IA currents and increasing neuronal excitability. Pharmacological inhibition of Kv4.3 with phrixotoxin-2 reproduced cold hypersensitivity; pharmacological potentiation of Kv4.3 amplified IA and alleviated cold hypersensitivity.","method":"Immunostaining, whole-cell patch clamp in dissociated TG neurons, orofacial operant behavioral test, phrixotoxin-2 injection and Kv4.3 activator application in ION-CCI rats","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Moderate — bidirectional pharmacological manipulation of Kv4.3 with behavioral and electrophysiological readouts in injury model, single lab","pmids":["33472822","29313436"],"is_preprint":false},{"year":2019,"finding":"Novel SCA19/22-associated KCND3 mutations (C317Y, P375S, V338E, T377M) all exhibit loss-of-function phenotypes: reduced current amplitudes, enhanced protein degradation, and defective membrane trafficking in heterologous expression. Co-expression of mutant and WT Kv4.3 demonstrates dominant-negative effects on protein biosynthesis and voltage-dependent gating of WT channels.","method":"In vitro heterologous expression, whole-cell patch clamp, protein biochemistry (Western blot for degradation), immunofluorescence for membrane trafficking, co-expression of mutant+WT","journal":"Human mutation","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple mutations characterized by electrophysiology, biochemistry, and localization in one study demonstrating dominant-negative mechanism, single lab","pmids":["31293010"],"is_preprint":false},{"year":2019,"finding":"De novo KCND3 mutation G306A (Gly306Ala) associated with early repolarization syndrome produces gain-of-function: increased current density, slow inactivation, and slow recovery from inactivation compared to WT. Quinidine restores inactivation kinetics of mutant Kv4.3, consistent with its clinical efficacy in the patient.","method":"Whole exome sequencing, whole-cell patch clamp in cultured cells, action potential simulation","journal":"Heart rhythm","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — single de novo mutation with electrophysiology and drug response, single patient and lab","pmids":["31173922"],"is_preprint":false},{"year":2020,"finding":"Alternative isoforms of Kv4 auxiliary subunits (KChIP1 vs KChIP4e and DPP6S) expressed in different CCK+ interneurons determine their firing phenotype. Neurons expressing KChIP4e and DPP6S with Kv4.3 display distinct low-voltage-activated K+ currents and a previously undetected membrane potential-dependent firing phenotype, while neurons with KChIP1 fire regularly, demonstrating that auxiliary subunit isoform identity specifies neuronal excitability.","method":"Whole-cell patch clamp in rat hippocampal CA3 slices, single-cell transcriptomics (gene profiling), immunofluorescence, pharmacology","journal":"eLife","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — correlation of auxiliary subunit isoforms with firing phenotype confirmed by multiple methods, but causal direction primarily inferred from natural variation rather than direct manipulation","pmids":["32490811"],"is_preprint":false},{"year":2021,"finding":"The miR-27a-3p/Hoxa10/Kv4.3 axis mediates Ang II-induced cardiomyocyte hypertrophy: miR-27a-3p targets the 3'UTR of Hoxa10 (confirmed by luciferase assay), reducing Hoxa10 protein; Hoxa10 overexpression reverses hypertrophy and electrical remodeling and positively regulates Kv4.3 expression.","method":"Ang II-induced cardiomyocyte hypertrophy model, luciferase reporter assay for miR-27a-3p targeting of Hoxa10 3'UTR, miR-27a-3p inhibitor, Hoxa10 overexpression, Western blot, RT-PCR","journal":"Frontiers in pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — luciferase assay confirms direct miRNA-3'UTR interaction; overexpression rescue links Hoxa10 to Kv4.3, single lab","pmids":["34248630"],"is_preprint":false},{"year":2022,"finding":"Acacetin (natural flavone) inhibits KCND3-encoded Kv4.3 WT with IC50 of 7.2 µM. KCND3-V392I gain-of-function mutation increases Ito by 92% in HEK cells and 61% in patient-derived iPSC-CMs; 30 µM acacetin inhibited V392I peak Ito by 96% and abolished the accentuated action potential notch in V392I iPSC-CMs.","method":"Site-directed mutagenesis, whole-cell patch clamp in TSA201 cells, gene-edited isogenic and patient-specific iPSC-CMs with multielectrode array and patch clamp, Western blot, immunocytochemistry","journal":"Circulation. Genomic and precision medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — mutant characterized in heterologous cells and validated in iPSC-CMs with isogenic controls; pharmacological rescue demonstrated at multiple levels (current and action potential), single lab multiple orthogonal methods","pmids":["35861988"],"is_preprint":false}],"current_model":"KCND3-encoded Kv4.3 is a voltage-gated, rapidly inactivating A-type K+ channel that serves as the primary pore-forming subunit of the cardiac transient outward current (Ito) and neuronal IA current; it forms macromolecular complexes with auxiliary subunits (KChIP1-4, DPPX/DPP6, DPP10, KvB2, KCNE2) that control plasma membrane trafficking, inactivation gating kinetics, and current density. Kv4.3 gating is regulated by direct phosphorylation at S550 by CaMKII (slowing inactivation) and isoform-specifically by PKCα (reducing current) and PKC via T504 (isoform-specific closed-state inactivation modulation). The channel also physically associates with AT1R (mediating angiotensin II-induced internalization) and sequesters inactive CaMKII at the membrane to suppress its activation. At the transcriptional/post-transcriptional level, Kv4.3 expression is reduced by angiotensin II (via NADPH oxidase-p38 MAPK-AUF1-mediated mRNA destabilization through the 3'UTR ARE), by phenylephrine (via promoter suppression), and by NRSF-mediated epigenetic silencing (histone H4 deacetylation) after nerve injury; TRα1 activates and TRβ1 suppresses KCND3 transcription through distinct promoter elements. Loss-of-function KCND3 mutations cause SCA19/22 through ER retention, protein instability, and dominant-negative suppression of WT channel function, while gain-of-function mutations underlie Brugada syndrome, early repolarization syndrome, and atrial fibrillation through enhanced Ito. In neurons, Kv4.3 underlies subthreshold membrane potential oscillations in specific hippocampal interneurons and A-type currents in nociceptive trigeminal ganglion neurons, where its downregulation contributes to neuropathic pain."},"narrative":{"mechanistic_narrative":"KCND3 encodes Kv4.3, the pore-forming subunit of a rapidly inactivating, voltage-gated A-type K+ channel that constitutes the principal molecular correlate of the cardiac transient outward current (Ito) and contributes to neuronal A-type currents (IA) [PMID:8831489, PMID:20371829]. In the heart, Kv4.3-mediated Ito sets the action potential plateau and duration: overexpression abbreviates APD while dominant-negative suppression prolongs APD and the QT interval, and increased Ito antagonizes calcineurin/NFAT-driven hypertrophy [PMID:10772652, PMID:15557376]. Kv4.3 functions within a macromolecular complex whose biophysics are tuned by auxiliary subunits — KChIP isoforms increase current density, slow inactivation in a Ca2+-dependent manner, and accelerate recovery from inactivation, with KChIP-mediated palmitoylation and N-terminal interactions controlling membrane trafficking and acting as a slow inactivation gate, while dipeptidyl-peptidase-related subunits DPP6/DPPX and DPP10 and the KCNE2 and Kvβ subunits further shape inactivation gating and reconstitute native human Ito kinetics [PMID:12135940, PMID:12006572, PMID:19109250, PMID:15890703, PMID:16738002, PMID:11087728, PMID:20042375]. Channel gating is regulated by direct phosphorylation: CaMKII phosphorylates S550 to slow inactivation, and PKCα downregulates current while a long-isoform-specific T504 site governs PKC modulation of closed-state inactivation [PMID:15456698, PMID:21803046, PMID:19675305]. Kv4.3 also physically associates with the angiotensin II type-1 receptor, which drives Ang II-induced channel internalization, and sequesters inactive CaMKII at the membrane to suppress its autophosphorylation and downstream L-type Ca2+ current facilitation [PMID:15342638, PMID:21148163]. Kv4.3 abundance is controlled at multiple levels — Ang II destabilizes its mRNA through an AT1R/NADPH-oxidase/p38/AUF1 pathway acting on a 3'UTR AU-rich element, phenylephrine suppresses its promoter, NRSF epigenetically silences the gene via histone H4 deacetylation after nerve injury, and thyroid hormone receptors TRα1 and TRβ1 oppositely regulate its transcription [PMID:11249870, PMID:16556864, PMID:18789946, PMID:20006971, PMID:19171649]. Loss-of-function KCND3 mutations cause SCA19/22 through ER retention, protein instability, and dominant-negative suppression of wild-type channels, whereas gain-of-function mutations underlie Brugada syndrome, early repolarization syndrome, and atrial fibrillation by enhancing Ito [PMID:23280837, PMID:23280838, PMID:25854634, PMID:31293010, PMID:21349352, PMID:31173922, PMID:23400760]. In neurons, Kv4.3 underlies subthreshold membrane potential oscillations in hippocampal interneurons and A-type currents in nociceptive trigeminal neurons whose downregulation drives neuropathic cold hypersensitivity [PMID:17314290, PMID:33472822, PMID:29313436].","teleology":[{"year":1996,"claim":"Establishing the molecular identity of cardiac Ito was the foundational question; demonstrating that heterologous Kv4.3 reproduces the biophysics and pharmacology of native Ito identified the pore-forming subunit of this repolarizing current.","evidence":"Heterologous expression in oocytes/HEK with patch clamp and in situ hybridization across canine, human, and rat heart","pmids":["8831489"],"confidence":"High","gaps":["Did not address auxiliary subunit requirements for native current","Human-specific complex composition not resolved"]},{"year":1999,"claim":"Whether tissue-specific Kv4.3 isoforms differ functionally was unknown; cloning long and short variants showed a 19-amino-acid insertion shifts inactivation voltage dependence, explaining tissue-specific gating and window current differences.","evidence":"RT-PCR cloning and heterologous expression with patch clamp in oocytes and HEK cells (rat and human)","pmids":["9450548","10200233"],"confidence":"High","gaps":["Physiological consequence of isoform choice in vivo not established at this stage","Regulatory basis of tissue-specific splicing unknown"]},{"year":2002,"claim":"How native Ito kinetics arise from Kv4.3 alone was unresolved; KChIP2 subunits were shown to increase current density and tune inactivation/recovery in Ca2+-dependent and splice-variant-specific ways, with palmitoylation controlling membrane localization.","evidence":"Co-expression with KChIP2 isoforms, metabolic labeling for palmitoylation, mutagenesis, confocal imaging, and patch clamp","pmids":["12135940","12006572","12433945"],"confidence":"High","gaps":["Stoichiometry of the channel-KChIP complex not defined","Structural basis of the interaction not yet resolved"]},{"year":2000,"claim":"Whether Ito causally controls cardiac repolarization in vivo was untested; gain- and loss-of-function gene transfer demonstrated that Kv4.3-mediated Ito sets plateau potential and APD and modulates QT.","evidence":"In vivo adenoviral Kv4.3 overexpression and dominant-negative W362F transfer with myocyte patch clamp and ECG","pmids":["10772652"],"confidence":"High","gaps":["Species-specific Ito subunit dependence not addressed","Link to hypertrophy not yet made"]},{"year":2001,"claim":"The mechanism of Kv4.3 downregulation in hypertrophy was unknown; Ang II and phenylephrine were shown to act through distinct pathways — mRNA destabilization versus promoter suppression respectively.","evidence":"RNase protection, mRNA turnover, and promoter-reporter assays in neonatal rat cardiac myocytes","pmids":["11249870"],"confidence":"High","gaps":["Identity of the mRNA-destabilizing factor not yet known","Promoter elements targeted by PE not mapped"]},{"year":2004,"claim":"How Kv4.3 gating is regulated by signaling was open; CaMKII was shown to directly phosphorylate S550 to slow inactivation and accelerate recovery, while AT1R was found to physically complex with Kv4.3 and mediate Ang II-induced internalization.","evidence":"Site-directed mutagenesis with CaMKII dialysis/inhibitory peptides; co-IP from canine ventricle plus FRET and patch clamp","pmids":["15456698","15342638"],"confidence":"High","gaps":["Phosphatase counter-regulation not defined","Trafficking machinery of AT1R-driven internalization unresolved"]},{"year":2005,"claim":"What additional subunits reconstitute native human Ito was unresolved; DPPX/DPP6 was shown to be required, and combined with KChIP2a yields current matching native human ventricular Ito, with DPP6 protein present in human but not rat ventricle.","evidence":"qRT-PCR, Western blot, CHO co-expression, and patch clamp comparison to native human Ito","pmids":["15890703"],"confidence":"High","gaps":["Full subunit stoichiometry of the native complex not resolved","Species differences in complex composition incompletely mapped"]},{"year":2006,"claim":"The molecular effector destabilizing Kv4.3 mRNA and the role of Kv4.3 as a CaMKII scaffold were defined; AUF1 acting on a 3'UTR ARE downstream of AT1R/NADPH-oxidase/p38 mediates mRNA decay, and Kv4.3 basally binds CaMKII to concentrate it at the membrane.","evidence":"3'UTR reporter/mutagenesis with AUF1 overexpression/knockdown and RNA pull-down; co-IP from ventricular myocytes with patch clamp","pmids":["16556864","16648177","18789946"],"confidence":"High","gaps":["In vivo contribution of AUF1 to disease remodeling not established","Dynamic regulation of CaMKII sequestration not fully resolved"]},{"year":2007,"claim":"Whether Kv4.3 is essential for native A-type currents was tested genetically; Kv4.3 knockout did not eliminate mouse ventricular Ito,f but selectively contributes to neuronal A-type currents underlying subthreshold oscillations.","evidence":"Kv4.3-/- mice with patch clamp and biochemistry; siRNA knockdown in hippocampal interneurons in acute slices","pmids":["18045613","17314290"],"confidence":"High","gaps":["Functional redundancy with Kv4.2 in heart not fully dissected","Neuronal versus cardiac subunit dependence differs and is incompletely explained"]},{"year":2008,"claim":"The structural basis of KChIP modulation was unknown; the KChIP4a crystal structure with competitive Kv4.3 N-terminal peptide binding revealed a released KChIP N-terminus acting as a slow inactivation gate.","evidence":"X-ray crystallography (3.0 Å), competition binding, and chimeric channel electrophysiology","pmids":["19109250"],"confidence":"High","gaps":["Full assembled channel-KChIP structure not solved","Generalizability across all KChIP isoforms not established"]},{"year":2009,"claim":"Multiple layers of Kv4.3 regulation were dissected: isoform-specific PKC modulation via T504 and PKCα-dependent current reduction, divergent thyroid-hormone-receptor transcriptional control, additional subunits (KCNE2, DPP10), toxin binding sites, and NRSF-mediated epigenetic silencing after nerve injury.","evidence":"Mutagenesis with PKC application, promoter-reporter/deletion mapping, co-expression electrophysiology, alanine scanning, and ChIP with NRSF knockdown","pmids":["19675305","21803046","19171649","20042375","16738002","19357248","20006971","20044444"],"confidence":"High","gaps":["Integration of competing transcriptional inputs in vivo unclear","Crosstalk among the multiple regulatory pathways not modeled"]},{"year":2010,"claim":"The functional consequence of the Kv4.3-CaMKII complex and the neuronal subunit hierarchy were clarified; Kv4.3 binds CaMKII calmodulin sites to suppress its autophosphorylation and L-type Ca2+ current facilitation, and genetic dissection placed Kv4.3 alongside Kv4.2 and Kv1.4 as distinct IA components.","evidence":"Co-IP/FRET and patch clamp in cardiomyocytes; single/double knockout mice with cortical neuron patch clamp","pmids":["21148163","20371829"],"confidence":"High","gaps":["Stoichiometry of CaMKII sequestration in vivo not quantified","Relative neuronal subunit contributions vary by cell type"]},{"year":2012,"claim":"The disease genetics of KCND3 were established; loss-of-function mutations cause SCA19/22 via ER retention and protein instability, while distinct gain-of-function mutations enhance Ito to cause Brugada syndrome and arrhythmias.","evidence":"Exome/Sanger sequencing, heterologous expression with localization and patch clamp, autopsy immunohistochemistry, and AP simulation","pmids":["23280837","23280838","21349352","22023388"],"confidence":"High","gaps":["Genotype-phenotype correlations across mutation spectrum incomplete","Mechanism of ER quality-control recognition not defined"]},{"year":2015,"claim":"How loss-of-function mutants affect wild-type channels was unresolved; SCA19/22 mutants exert dominant-negative suppression of WT Kv4.3 trafficking and gating, with KChIP2 partially rescuing, and a voltage-sensor RVF duplication shows extra S4 charge profoundly impairs gating.","evidence":"Mutant/WT co-expression with surface expression and patch clamp plus KChIP2 rescue; exome sequencing with electrophysiology","pmids":["25854634","26189493"],"confidence":"High","gaps":["In vivo dominant-negative penetrance in patients not quantified","Whether KChIP2 rescue is therapeutically achievable unknown"]},{"year":2014,"claim":"Endogenous and pharmacological modulators of Kv4.3 were identified; SEMA3A acts as a direct protein inhibitor whose disease mutations cause Kv4.3 gain-of-function, and NS5806 enhances current via Ca2+-dependent KChIP3 binding.","evidence":"Co-IP, domain-disruption mutagenesis, iPSC-CM assays, and biophysical binding (ITC/fluorescence) with mutagenesis","pmids":["24963029","25228688"],"confidence":"High","gaps":["Physiological setting of SEMA3A-Kv4.3 regulation not fully defined","In vivo efficacy of small-molecule modulators not established"]},{"year":2022,"claim":"Translating Kv4.3 mechanism to precision therapy was the goal; patient-derived and isogenic iPSC-CM models confirmed gain-of-function mutations and demonstrated that channel blockers (acacetin, quinidine) normalize Ito and the action potential notch.","evidence":"Mutagenesis, heterologous and patient/isogenic iPSC-CM patch clamp and multielectrode array with pharmacology","pmids":["35861988","31173922","23400760","29313436","31293010"],"confidence":"High","gaps":["Clinical efficacy of these blockers across mutation classes untested","Long-term safety of Ito-targeted therapy unknown"]},{"year":null,"claim":"How the multiple, often opposing regulatory inputs (phosphorylation, subunit composition, receptor coupling, transcriptional and post-transcriptional control) are integrated to set Kv4.3 surface density and gating in specific cardiac and neuronal cell types in vivo remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified quantitative model of complex assembly and regulation","Cell-type-specific subunit/regulator combinations incompletely mapped","In vivo therapeutic targeting not validated"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[0,2,4]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,4,38]},{"term_id":"GO:0140313","term_label":"molecular sequestering activity","supporting_discovery_ids":[28]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[8,12,28,32]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[32,33]}],"pathway":[{"term_id":"R-HSA-397014","term_label":"Muscle contraction","supporting_discovery_ids":[4,14]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[19,29,42]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[12,16,22,28]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[31,32,33,34]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[6,40,23]}],"complexes":["Kv4.3-KChIP2 channel complex","Kv4.3-KChIP-DPP6/DPPX native cardiac Ito complex","Kv4.3-AT1R complex","Kv4.3-CaMKII membrane complex"],"partners":["KCNIP2","DPP6","DPP10","KCNE2","KCNAB2","AGTR1","CAMK2","SEMA3A"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9UK17","full_name":"A-type voltage-gated potassium channel KCND3","aliases":["Potassium voltage-gated channel subfamily D member 3","Voltage-gated potassium channel subunit Kv4.3"],"length_aa":655,"mass_kda":73.5,"function":"Pore-forming (alpha) subunit of voltage-gated A-type potassium channels that mediates transmembrane potassium transport in excitable membranes, in brain and heart (PubMed:10200233, PubMed:17187064, PubMed:21349352, PubMed:22457051, PubMed:23280837, PubMed:23280838, PubMed:34997220, PubMed:9843794). In cardiomyocytes, may generate the transient outward potassium current I(To) (By similarity). In neurons, may conduct the transient subthreshold somatodendritic A-type potassium current (ISA) (By similarity). Kinetics properties are characterized by fast activation at subthreshold membrane potentials, rapid inactivation, and quick recovery from inactivation (PubMed:10200233, PubMed:17187064, PubMed:21349352, PubMed:22457051, PubMed:23280837, PubMed:23280838, PubMed:34997220, PubMed:9843794). Channel properties are modulated by interactions with regulatory subunits (PubMed:17187064, PubMed:34997220). Interaction with the regulatory subunits KCNIP1 or KCNIP2 modulates the channel gating kinetics namely channel activation and inactivation kinetics and rate of recovery from inactivation (PubMed:17187064, PubMed:34997220). Likewise, interaction with DPP6 modulates the channel gating kinetics namely channel activation and inactivation kinetics (PubMed:34997220)","subcellular_location":"Cell membrane; Cell membrane, sarcolemma; Cell projection, dendrite","url":"https://www.uniprot.org/uniprotkb/Q9UK17/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/KCND3","classification":"Not Classified","n_dependent_lines":71,"n_total_lines":1208,"dependency_fraction":0.058774834437086095},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/KCND3","total_profiled":1310},"omim":[{"mim_id":"616399","title":"BRUGADA SYNDROME 9; BRGDA9","url":"https://www.omim.org/entry/616399"},{"mim_id":"608182","title":"POTASSIUM CHANNEL-INTERACTING PROTEIN 4","url":"https://www.omim.org/entry/608182"},{"mim_id":"607346","title":"SPINOCEREBELLAR ATAXIA 19; SCA19","url":"https://www.omim.org/entry/607346"},{"mim_id":"605411","title":"POTASSIUM VOLTAGE-GATED CHANNEL, SHAL-RELATED SUBFAMILY, MEMBER 3; KCND3","url":"https://www.omim.org/entry/605411"},{"mim_id":"605410","title":"POTASSIUM VOLTAGE-GATED CHANNEL, SHAL-RELATED SUBFAMILY, MEMBER 2; KCND2","url":"https://www.omim.org/entry/605410"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":28.5}],"url":"https://www.proteinatlas.org/search/KCND3"},"hgnc":{"alias_symbol":["Kv4.3","KSHIVB"],"prev_symbol":["SCA22","SCA19"]},"alphafold":{"accession":"Q9UK17","domains":[{"cath_id":"3.30.710.10","chopping":"40-155","consensus_level":"high","plddt":89.7384,"start":40,"end":155},{"cath_id":"1.20.120.350","chopping":"175-303","consensus_level":"high","plddt":86.4995,"start":175,"end":303},{"cath_id":"1.10.287.70","chopping":"311-418","consensus_level":"high","plddt":91.2797,"start":311,"end":418}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UK17","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UK17-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UK17-F1-predicted_aligned_error_v6.png","plddt_mean":70.44},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=KCND3","jax_strain_url":"https://www.jax.org/strain/search?query=KCND3"},"sequence":{"accession":"Q9UK17","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9UK17.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9UK17/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UK17"}},"corpus_meta":[{"pmid":"8831489","id":"PMC_8831489","title":"Role of the Kv4.3 K+ channel in ventricular muscle. A molecular correlate for the transient outward current.","date":"1996","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/8831489","citation_count":389,"is_preprint":false},{"pmid":"9760292","id":"PMC_9760292","title":"Molecular basis of transient outward potassium current downregulation in human heart failure: a decrease in Kv4.3 mRNA correlates with a reduction in current density.","date":"1998","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/9760292","citation_count":321,"is_preprint":false},{"pmid":"21349352","id":"PMC_21349352","title":"Transient outward current (I(to)) gain-of-function mutations in the KCND3-encoded Kv4.3 potassium channel and Brugada syndrome.","date":"2011","source":"Heart rhythm","url":"https://pubmed.ncbi.nlm.nih.gov/21349352","citation_count":188,"is_preprint":false},{"pmid":"23280837","id":"PMC_23280837","title":"Mutations in KCND3 cause spinocerebellar ataxia type 22.","date":"2012","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/23280837","citation_count":126,"is_preprint":false},{"pmid":"12006572","id":"PMC_12006572","title":"Palmitoylation of KChIP splicing variants is required for efficient cell surface expression of Kv4.3 channels.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12006572","citation_count":116,"is_preprint":false},{"pmid":"23280838","id":"PMC_23280838","title":"Mutations in potassium channel kcnd3 cause spinocerebellar ataxia type 19.","date":"2012","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/23280838","citation_count":114,"is_preprint":false},{"pmid":"15890703","id":"PMC_15890703","title":"Expression and function of dipeptidyl-aminopeptidase-like protein 6 as a putative beta-subunit of human cardiac transient outward current encoded by Kv4.3.","date":"2005","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/15890703","citation_count":102,"is_preprint":false},{"pmid":"12135940","id":"PMC_12135940","title":"Regulation of Kv4.3 current by KChIP2 splice variants: a component of native cardiac I(to)?","date":"2002","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/12135940","citation_count":101,"is_preprint":false},{"pmid":"9450548","id":"PMC_9450548","title":"Molecular cloning and tissue distribution of an alternatively spliced variant of an A-type K+ channel alpha-subunit, Kv4.3 in the rat.","date":"1997","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/9450548","citation_count":101,"is_preprint":false},{"pmid":"23400760","id":"PMC_23400760","title":"A novel KCND3 gain-of-function mutation associated with early-onset of persistent lone atrial fibrillation.","date":"2013","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/23400760","citation_count":100,"is_preprint":false},{"pmid":"10973847","id":"PMC_10973847","title":"Nicotine is a potent blocker of the cardiac A-type K(+) channels. Effects on cloned Kv4.3 channels and native transient outward current.","date":"2000","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/10973847","citation_count":96,"is_preprint":false},{"pmid":"9314834","id":"PMC_9314834","title":"Decreased expression of Kv4.2 and novel Kv4.3 K+ channel subunit mRNAs in ventricles of renovascular hypertensive rats.","date":"1997","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/9314834","citation_count":90,"is_preprint":false},{"pmid":"10330244","id":"PMC_10330244","title":"Regional contributions of Kv1.4, Kv4.2, and Kv4.3 to transient outward K+ current in rat ventricle.","date":"1999","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/10330244","citation_count":88,"is_preprint":false},{"pmid":"20006971","id":"PMC_20006971","title":"Neuron-restrictive silencer factor causes epigenetic silencing of Kv4.3 gene after peripheral nerve injury.","date":"2009","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/20006971","citation_count":86,"is_preprint":false},{"pmid":"10868735","id":"PMC_10868735","title":"Molecular remodeling of Kv4.3 potassium channels in human atrial fibrillation.","date":"2000","source":"Journal of cardiovascular electrophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/10868735","citation_count":82,"is_preprint":false},{"pmid":"11087728","id":"PMC_11087728","title":"Kvbeta subunits increase expression of Kv4.3 channels by interacting with their C termini.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11087728","citation_count":80,"is_preprint":false},{"pmid":"17122053","id":"PMC_17122053","title":"Differential expression of I(A) channel subunits Kv4.2 and Kv4.3 in mouse visual cortical neurons and synapses.","date":"2006","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/17122053","citation_count":69,"is_preprint":false},{"pmid":"15456698","id":"PMC_15456698","title":"Regulation of Kv4.3 currents by Ca2+/calmodulin-dependent protein kinase II.","date":"2004","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/15456698","citation_count":68,"is_preprint":false},{"pmid":"11249870","id":"PMC_11249870","title":"Independent regulation of cardiac Kv4.3 potassium channel expression by angiotensin II and phenylephrine.","date":"2001","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/11249870","citation_count":66,"is_preprint":false},{"pmid":"12433945","id":"PMC_12433945","title":"Elucidating KChIP effects on Kv4.3 inactivation and recovery kinetics with a minimal KChIP2 isoform.","date":"2002","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12433945","citation_count":65,"is_preprint":false},{"pmid":"16556864","id":"PMC_16556864","title":"Angiotensin II and stretch activate NADPH oxidase to destabilize cardiac Kv4.3 channel mRNA.","date":"2006","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/16556864","citation_count":64,"is_preprint":false},{"pmid":"17314290","id":"PMC_17314290","title":"Kv4.3-mediated A-type K+ currents underlie rhythmic activity in hippocampal interneurons.","date":"2007","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/17314290","citation_count":62,"is_preprint":false},{"pmid":"10772652","id":"PMC_10772652","title":"Molecular dissection of cardiac repolarization by in vivo Kv4.3 gene transfer.","date":"2000","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/10772652","citation_count":62,"is_preprint":false},{"pmid":"12764052","id":"PMC_12764052","title":"A novel autosomal dominant spinocerebellar ataxia (SCA22) linked to chromosome 1p21-q23.","date":"2003","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/12764052","citation_count":60,"is_preprint":false},{"pmid":"22457051","id":"PMC_22457051","title":"Novel mutations in the KCND3-encoded Kv4.3 K+ channel associated with autopsy-negative sudden unexplained death.","date":"2012","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/22457051","citation_count":59,"is_preprint":false},{"pmid":"14724186","id":"PMC_14724186","title":"Regulation of Kv4.3 voltage-dependent gating kinetics by KChIP2 isoforms.","date":"2004","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/14724186","citation_count":59,"is_preprint":false},{"pmid":"15342638","id":"PMC_15342638","title":"Angiotensin receptor type 1 forms a complex with the transient outward potassium channel Kv4.3 and regulates its gating properties and intracellular localization.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15342638","citation_count":59,"is_preprint":false},{"pmid":"20371829","id":"PMC_20371829","title":"Molecular dissection of I(A) in cortical pyramidal neurons reveals three distinct components encoded by Kv4.2, Kv4.3, and Kv1.4 alpha-subunits.","date":"2010","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/20371829","citation_count":57,"is_preprint":false},{"pmid":"9001401","id":"PMC_9001401","title":"Cloning, expression and CNS distribution of Kv4.3, an A-type K+ channel alpha subunit.","date":"1997","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/9001401","citation_count":55,"is_preprint":false},{"pmid":"26189493","id":"PMC_26189493","title":"First de novo KCND3 mutation causes severe Kv4.3 channel dysfunction leading to early onset cerebellar ataxia, intellectual disability, oral apraxia and epilepsy.","date":"2015","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26189493","citation_count":51,"is_preprint":false},{"pmid":"20044444","id":"PMC_20044444","title":"Downregulated Kv4.3 expression in the RVLM as a potential mechanism for sympathoexcitation in rats with chronic heart failure.","date":"2009","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/20044444","citation_count":51,"is_preprint":false},{"pmid":"12384780","id":"PMC_12384780","title":"Identification of a novel SCA locus ( SCA19) in a Dutch autosomal dominant cerebellar ataxia family on chromosome region 1p21-q21.","date":"2002","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12384780","citation_count":50,"is_preprint":false},{"pmid":"16648177","id":"PMC_16648177","title":"Differential modulation of Kv4.2 and Kv4.3 channels by calmodulin-dependent protein kinase II in rat cardiac myocytes.","date":"2006","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16648177","citation_count":50,"is_preprint":false},{"pmid":"15557376","id":"PMC_15557376","title":"In vivo cardiac gene transfer of Kv4.3 abrogates the hypertrophic response in rats after aortic stenosis.","date":"2004","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/15557376","citation_count":49,"is_preprint":false},{"pmid":"24963029","id":"PMC_24963029","title":"Characterization of SEMA3A-encoded semaphorin as a naturally occurring Kv4.3 protein inhibitor and its contribution to Brugada syndrome.","date":"2014","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/24963029","citation_count":46,"is_preprint":false},{"pmid":"18045613","id":"PMC_18045613","title":"Kv4.3 is not required for the generation of functional Ito,f channels in adult mouse ventricles.","date":"2007","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/18045613","citation_count":43,"is_preprint":false},{"pmid":"18678642","id":"PMC_18678642","title":"Nitric oxide inhibits Kv4.3 and human cardiac transient outward potassium current (Ito1).","date":"2008","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/18678642","citation_count":42,"is_preprint":false},{"pmid":"10325966","id":"PMC_10325966","title":"Characterisation of Kv4.3 in HEK293 cells: comparison with the rat ventricular transient outward potassium current.","date":"1999","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/10325966","citation_count":39,"is_preprint":false},{"pmid":"31173922","id":"PMC_31173922","title":"A de novo gain-of-function KCND3 mutation in early repolarization syndrome.","date":"2019","source":"Heart rhythm","url":"https://pubmed.ncbi.nlm.nih.gov/31173922","citation_count":36,"is_preprint":false},{"pmid":"29313436","id":"PMC_29313436","title":"Down-regulation of Kv4.3 channels and a-type K+ currents in V2 trigeminal ganglion neurons of rats following oxaliplatin treatment.","date":"2018","source":"Molecular pain","url":"https://pubmed.ncbi.nlm.nih.gov/29313436","citation_count":35,"is_preprint":false},{"pmid":"10325968","id":"PMC_10325968","title":"Functional expression of an inactivating potassium channel (Kv4.3) in a mammalian cell line.","date":"1999","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/10325968","citation_count":35,"is_preprint":false},{"pmid":"30776697","id":"PMC_30776697","title":"Gene mutational analysis in a cohort of Chinese children with unexplained epilepsy: Identification of a new KCND3 phenotype and novel genes causing Dravet syndrome.","date":"2019","source":"Seizure","url":"https://pubmed.ncbi.nlm.nih.gov/30776697","citation_count":34,"is_preprint":false},{"pmid":"10200233","id":"PMC_10200233","title":"Cloning and expression of the human kv4.3 potassium channel.","date":"1999","source":"Journal of neurophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/10200233","citation_count":34,"is_preprint":false},{"pmid":"12788813","id":"PMC_12788813","title":"Dihydropyridine Ca2+ channel antagonists and agonists block Kv4.2, Kv4.3 and Kv1.4 K+ channels expressed in HEK293 cells.","date":"2003","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/12788813","citation_count":33,"is_preprint":false},{"pmid":"19616555","id":"PMC_19616555","title":"Endocannabinoids and cannabinoid analogues block human cardiac Kv4.3 channels in a receptor-independent manner.","date":"2009","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/19616555","citation_count":32,"is_preprint":false},{"pmid":"12911756","id":"PMC_12911756","title":"Contrasting expression of Kv4.3, an A-type K+ channel, in migrating Purkinje cells and other post-migratory cerebellar neurons.","date":"2003","source":"The European journal of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/12911756","citation_count":32,"is_preprint":false},{"pmid":"16738002","id":"PMC_16738002","title":"DPP10 is an inactivation modulatory protein of Kv4.3 and Kv1.4.","date":"2006","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16738002","citation_count":31,"is_preprint":false},{"pmid":"25228688","id":"PMC_25228688","title":"Modulation of the voltage-gated potassium channel (Kv4.3) and the auxiliary protein (KChIP3) interactions by the current activator NS5806.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25228688","citation_count":31,"is_preprint":false},{"pmid":"30634540","id":"PMC_30634540","title":"Expression, Cellular and Subcellular Localisation of Kv4.2 and Kv4.3 Channels in the Rodent Hippocampus.","date":"2019","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30634540","citation_count":30,"is_preprint":false},{"pmid":"12150935","id":"PMC_12150935","title":"Kinetic properties of Kv4.3 and their modulation by KChIP2b.","date":"2002","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/12150935","citation_count":30,"is_preprint":false},{"pmid":"10433502","id":"PMC_10433502","title":"Blockade by N-3 polyunsaturated fatty acid of the Kv4.3 current stably expressed in Chinese hamster ovary cells.","date":"1999","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/10433502","citation_count":29,"is_preprint":false},{"pmid":"21148163","id":"PMC_21148163","title":"Dynamic Kv4.3-CaMKII unit in heart: an intrinsic negative regulator for CaMKII activation.","date":"2010","source":"European heart journal","url":"https://pubmed.ncbi.nlm.nih.gov/21148163","citation_count":28,"is_preprint":false},{"pmid":"33472822","id":"PMC_33472822","title":"Kv4.3 Channel Dysfunction Contributes to Trigeminal Neuropathic Pain Manifested with Orofacial Cold Hypersensitivity in Rats.","date":"2021","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/33472822","citation_count":27,"is_preprint":false},{"pmid":"19109250","id":"PMC_19109250","title":"Structural Insights into KChIP4a Modulation of Kv4.3 Inactivation.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19109250","citation_count":27,"is_preprint":false},{"pmid":"20483361","id":"PMC_20483361","title":"High-mobility group box 1 (HMGB1) downregulates cardiac transient outward potassium current (Ito) through downregulation of Kv4.2 and Kv4.3 channel transcripts and proteins.","date":"2010","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/20483361","citation_count":27,"is_preprint":false},{"pmid":"25854634","id":"PMC_25854634","title":"Spinocerebellar ataxia type 19/22 mutations alter heterocomplex Kv4.3 channel function and gating in a dominant manner.","date":"2015","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/25854634","citation_count":26,"is_preprint":false},{"pmid":"15980874","id":"PMC_15980874","title":"Spironolactone and its main metabolite canrenoic acid block hKv1.5, Kv4.3 and Kv7.1 + minK channels.","date":"2005","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/15980874","citation_count":26,"is_preprint":false},{"pmid":"21232039","id":"PMC_21232039","title":"Rosiglitazone inhibits Kv4.3 potassium channels by open-channel block and acceleration of closed-state inactivation.","date":"2011","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/21232039","citation_count":26,"is_preprint":false},{"pmid":"20858500","id":"PMC_20858500","title":"Celecoxib blocks cardiac Kv1.5, Kv4.3 and Kv7.1 (KCNQ1) channels: effects on cardiac action potentials.","date":"2010","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/20858500","citation_count":25,"is_preprint":false},{"pmid":"12172648","id":"PMC_12172648","title":"External pore collapse as an inactivation mechanism for Kv4.3 K+ channels.","date":"2002","source":"The Journal of membrane biology","url":"https://pubmed.ncbi.nlm.nih.gov/12172648","citation_count":25,"is_preprint":false},{"pmid":"32823520","id":"PMC_32823520","title":"KCND3-Related Neurological Disorders: From Old to Emerging Clinical Phenotypes.","date":"2020","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32823520","citation_count":24,"is_preprint":false},{"pmid":"28947073","id":"PMC_28947073","title":"Expanding the phenotype of SCA19/22: Parkinsonism, cognitive impairment and epilepsy.","date":"2017","source":"Parkinsonism & related disorders","url":"https://pubmed.ncbi.nlm.nih.gov/28947073","citation_count":24,"is_preprint":false},{"pmid":"20042375","id":"PMC_20042375","title":"KCNE2 modulation of Kv4.3 current and its potential role in fatal rhythm disorders.","date":"2009","source":"Heart rhythm","url":"https://pubmed.ncbi.nlm.nih.gov/20042375","citation_count":24,"is_preprint":false},{"pmid":"15537499","id":"PMC_15537499","title":"Diltiazem inhibits hKv1.5 and Kv4.3 currents at therapeutic concentrations.","date":"2004","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/15537499","citation_count":23,"is_preprint":false},{"pmid":"18536731","id":"PMC_18536731","title":"Effects of MiRP1 and DPP6 beta-subunits on the blockade induced by flecainide of Kv4.3/KChIP2 channels.","date":"2008","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/18536731","citation_count":23,"is_preprint":false},{"pmid":"22023388","id":"PMC_22023388","title":"Large T-antigen up-regulates Kv4.3 K⁺ channels through Sp1, and Kv4.3 K⁺ channels contribute to cell apoptosis and necrosis through activation of calcium/calmodulin-dependent protein kinase II.","date":"2012","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/22023388","citation_count":23,"is_preprint":false},{"pmid":"19357248","id":"PMC_19357248","title":"S3b amino acid substitutions and ancillary subunits alter the affinity of Heteropoda venatoria toxin 2 for Kv4.3.","date":"2009","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/19357248","citation_count":23,"is_preprint":false},{"pmid":"15895560","id":"PMC_15895560","title":"Clinical, psychological, and genetic characteristics of spinocerebellar ataxia type 19 (SCA19).","date":"2005","source":"Cerebellum (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/15895560","citation_count":22,"is_preprint":false},{"pmid":"24762397","id":"PMC_24762397","title":"The potential role of Kv4.3 K+ channel in heart hypertrophy.","date":"2014","source":"Channels (Austin, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/24762397","citation_count":22,"is_preprint":false},{"pmid":"17312186","id":"PMC_17312186","title":"Open channel block of A-type, kv4.3, and delayed rectifier K+ channels, Kv1.3 and Kv3.1, by sibutramine.","date":"2007","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/17312186","citation_count":22,"is_preprint":false},{"pmid":"14521958","id":"PMC_14521958","title":"Differential inhibition of transient outward currents of Kv1.4 and Kv4.3 by endothelin.","date":"2003","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/14521958","citation_count":21,"is_preprint":false},{"pmid":"16815868","id":"PMC_16815868","title":"Interaction of riluzole with the closed inactivated state of Kv4.3 channels.","date":"2006","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/16815868","citation_count":21,"is_preprint":false},{"pmid":"21129448","id":"PMC_21129448","title":"KChIP1 modulation of Kv4.3-mediated A-type K(+) currents and repetitive firing in hippocampal interneurons.","date":"2010","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/21129448","citation_count":20,"is_preprint":false},{"pmid":"23832378","id":"PMC_23832378","title":"Inhibition of cardiac Kv1.5 and Kv4.3 potassium channels by the class Ia anti-arrhythmic ajmaline: mode of action.","date":"2013","source":"Naunyn-Schmiedeberg's archives of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/23832378","citation_count":20,"is_preprint":false},{"pmid":"31293010","id":"PMC_31293010","title":"Novel SCA19/22-associated KCND3 mutations disrupt human KV 4.3 protein biosynthesis and channel gating.","date":"2019","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/31293010","citation_count":19,"is_preprint":false},{"pmid":"11270617","id":"PMC_11270617","title":"Regional expression of the splice variants of Kv4.3 in rat brain and effects of C-terminus deletion on expressed K+ currents.","date":"2001","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/11270617","citation_count":19,"is_preprint":false},{"pmid":"18401705","id":"PMC_18401705","title":"Enhanced trafficking of tetrameric Kv4.3 channels by KChIP1 clamping.","date":"2008","source":"Neurochemical research","url":"https://pubmed.ncbi.nlm.nih.gov/18401705","citation_count":18,"is_preprint":false},{"pmid":"28895081","id":"PMC_28895081","title":"Novel De Novo KCND3 Mutation in a Japanese Patient with Intellectual Disability, Cerebellar Ataxia, Myoclonus, and Dystonia.","date":"2018","source":"Cerebellum (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/28895081","citation_count":17,"is_preprint":false},{"pmid":"18789946","id":"PMC_18789946","title":"AUF1 is upregulated by angiotensin II to destabilize cardiac Kv4.3 channel mRNA.","date":"2008","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/18789946","citation_count":17,"is_preprint":false},{"pmid":"21148405","id":"PMC_21148405","title":"Inhibition of Kv4.3 by genistein via a tyrosine phosphorylation-independent mechanism.","date":"2010","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/21148405","citation_count":17,"is_preprint":false},{"pmid":"31600170","id":"PMC_31600170","title":"KCND3 potassium channel gene variant confers susceptibility to electrocardiographic early repolarization pattern.","date":"2019","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/31600170","citation_count":16,"is_preprint":false},{"pmid":"29383177","id":"PMC_29383177","title":"A novel KCND3 mutation associated with early-onset lone atrial fibrillation.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/29383177","citation_count":16,"is_preprint":false},{"pmid":"26721612","id":"PMC_26721612","title":"Role of Kv4.3 in Vibration-Induced Muscle Pain in the Rat.","date":"2015","source":"The journal of pain","url":"https://pubmed.ncbi.nlm.nih.gov/26721612","citation_count":16,"is_preprint":false},{"pmid":"10942109","id":"PMC_10942109","title":"Genomic organisation and chromosomal localisation of two members of the KCND ion channel family, KCND2 and KCND3.","date":"2000","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10942109","citation_count":15,"is_preprint":false},{"pmid":"12875427","id":"PMC_12875427","title":"Extracellular acidosis modulates drug block of Kv4.3 currents by flecainide and quinidine.","date":"2003","source":"Journal of cardiovascular electrophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/12875427","citation_count":15,"is_preprint":false},{"pmid":"23747723","id":"PMC_23747723","title":"Bone morphogenetic protein-4 contributes to the down-regulation of Kv4.3 K+ channels in pathological cardiac hypertrophy.","date":"2013","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/23747723","citation_count":15,"is_preprint":false},{"pmid":"26592512","id":"PMC_26592512","title":"Effects of neferine on Kv4.3 channels expressed in HEK293 cells and ex vivo electrophysiology of rabbit hearts.","date":"2015","source":"Acta pharmacologica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/26592512","citation_count":15,"is_preprint":false},{"pmid":"28544933","id":"PMC_28544933","title":"Cardiotoxic effect of levofloxacin and ciprofloxacin in rats with/without acute myocardial infarction: Impact on cardiac rhythm and cardiac expression of Kv4.3, Kv1.2 and Nav1.5 channels.","date":"2017","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/28544933","citation_count":15,"is_preprint":false},{"pmid":"35861988","id":"PMC_35861988","title":"Acacetin, a Potent Transient Outward Current Blocker, May Be a Novel Therapeutic for KCND3-Encoded Kv4.3 Gain-of-Function-Associated J-Wave Syndromes.","date":"2022","source":"Circulation. Genomic and precision medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35861988","citation_count":14,"is_preprint":false},{"pmid":"26374734","id":"PMC_26374734","title":"Analysis of SCA8, SCA10, SCA12, SCA17 and SCA19 in patients with unknown spinocerebellar ataxia: a Thai multicentre study.","date":"2015","source":"BMC neurology","url":"https://pubmed.ncbi.nlm.nih.gov/26374734","citation_count":14,"is_preprint":false},{"pmid":"34248630","id":"PMC_34248630","title":"MiR-27a-3p/Hoxa10 Axis Regulates Angiotensin II-Induced Cardiomyocyte Hypertrophy by Targeting Kv4.3 Expression.","date":"2021","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/34248630","citation_count":14,"is_preprint":false},{"pmid":"34361012","id":"PMC_34361012","title":"Rare Gain-of-Function KCND3 Variant Associated with Cerebellar Ataxia, Parkinsonism, Cognitive Dysfunction, and Brain Iron Accumulation.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34361012","citation_count":14,"is_preprint":false},{"pmid":"30462989","id":"PMC_30462989","title":"Kv4.3 expression abrogates and reverses norepinephrine-induced myocyte hypertrophy by CaMKII inhibition.","date":"2018","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/30462989","citation_count":13,"is_preprint":false},{"pmid":"19171649","id":"PMC_19171649","title":"Divergent regulation of cardiac KCND3 potassium channel expression by the thyroid hormone receptors alpha1 and beta1.","date":"2009","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/19171649","citation_count":13,"is_preprint":false},{"pmid":"26196737","id":"PMC_26196737","title":"Kv4.3-Encoded Fast Transient Outward Current Is Presented in Kv4.2 Knockout Mouse Cardiomyocytes.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26196737","citation_count":13,"is_preprint":false},{"pmid":"22618310","id":"PMC_22618310","title":"Duloxetine blocks cloned Kv4.3 potassium channels.","date":"2012","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/22618310","citation_count":13,"is_preprint":false},{"pmid":"26016905","id":"PMC_26016905","title":"Two novel Brugada syndrome-associated mutations increase KV4.3 membrane expression and function.","date":"2015","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26016905","citation_count":13,"is_preprint":false},{"pmid":"19675305","id":"PMC_19675305","title":"Closed-state inactivation in Kv4.3 isoforms is differentially modulated by protein kinase C.","date":"2009","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/19675305","citation_count":13,"is_preprint":false},{"pmid":"32490811","id":"PMC_32490811","title":"Functional specification of CCK+ interneurons by alternative isoforms of Kv4.3 auxiliary subunits.","date":"2020","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/32490811","citation_count":13,"is_preprint":false},{"pmid":"21803046","id":"PMC_21803046","title":"Central role of PKCα in isoenzyme-selective regulation of cardiac transient outward current Ito and Kv4.3 channels.","date":"2011","source":"Journal of molecular and cellular cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/21803046","citation_count":13,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":56833,"output_tokens":13170,"usd":0.184025,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":24657,"output_tokens":6082,"usd":0.137667,"stage2_stop_reason":"end_turn"},"total_usd":0.321692,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"Kv4.3 (KCND3) encodes a rapidly inactivating A-type K+ current with biophysical and pharmacological properties matching the native cardiac transient outward current (Ito) in canine ventricular myocytes, establishing Kv4.3 as the primary molecular correlate of Ito in canine and likely human heart.\",\n      \"method\": \"Heterologous expression in Xenopus oocytes and HEK cells, whole-cell patch clamp, in situ hybridization in canine, human, and rat heart\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct electrophysiological characterization in heterologous system plus native tissue correlation, replicated across multiple species\",\n      \"pmids\": [\"8831489\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"A novel alternatively spliced variant of Kv4.3 with a 19-amino acid insertion in the C-terminal intracellular region was cloned from rat vas deferens; this longer isoform is the predominant form in rat heart and smooth muscle, whereas the previously reported shorter form predominates in brain.\",\n      \"method\": \"RT-PCR cloning from rat vas deferens, functional expression in HEK293 cells, whole-cell patch clamp\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct cloning and functional expression with electrophysiological validation across multiple tissues\",\n      \"pmids\": [\"9450548\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Two human Kv4.3 isoforms (long and short, differing by a 19-amino acid sequence) were cloned and expressed; both produce A-type K+ currents in Xenopus oocytes, and the short isoform has its steady-state inactivation curve shifted ~10 mV positive relative to the long isoform, shifting the window current peak accordingly.\",\n      \"method\": \"RT-PCR cloning, heterologous expression in Xenopus oocytes, whole-cell patch clamp\",\n      \"journal\": \"Journal of neurophysiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct functional comparison of two cloned isoforms with electrophysiology, single lab\",\n      \"pmids\": [\"10200233\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Kvβ2 subunits co-associate with Kv4.3 proteins in the brain (co-immunoprecipitation). Kvβ1 or Kvβ2 expression increases Kv4.3 current density and protein expression without affecting channel gating. This association requires the C-terminus but not the N-terminus of Kv4.3, indicating a novel interaction mode distinct from Kv1-family channels.\",\n      \"method\": \"Co-immunoprecipitation from rat brain, co-expression in HEK cells, whole-cell patch clamp, Western blot\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP from native tissue plus heterologous expression with mutagenesis (C-terminus deletion), two orthogonal methods\",\n      \"pmids\": [\"11087728\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"In vivo adenoviral overexpression of Kv4.3 in guinea pig myocytes generates robust transient outward current that progressively depresses the plateau potential and abbreviates action potential duration (APD). Dominant-negative Kv4.3-W362F suppressed Ito in rat ventriculocytes, prolonged APD ~30%, and extended the QT interval, demonstrating that Ito plays a causal role in setting plateau potential and APD.\",\n      \"method\": \"In vivo intramyocardial adenoviral gene transfer, whole-cell patch clamp in isolated myocytes, surface ECG recording\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo gain- and loss-of-function with defined electrophysiological phenotypes, reciprocal approach using both overexpression and dominant-negative\",\n      \"pmids\": [\"10772652\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Nicotine potently blocks Kv4.3 channels (IC50 ~40 nM) via both tonic (40%) and use-dependent (60%) block. Single-channel analysis showed reduced conductance, open probability, and open time with increased closed time. Nicotine does not act through neurotransmitter receptors, indicating direct channel block.\",\n      \"method\": \"Whole-cell and single-channel patch clamp in Xenopus oocytes expressing Kv4.3, canine ventricular myocyte Ito recordings, pharmacological receptor antagonist experiments\",\n      \"journal\": \"Circulation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — single-channel and whole-cell analysis with receptor-antagonist controls establishing direct mechanism, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"10973847\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Angiotensin II (Ang II) downregulates Kv4.3 mRNA and protein by destabilizing the mRNA (accelerating degradation) without affecting transcription, whereas phenylephrine (PE) downregulates Kv4.3 by inhibiting promoter activity (transcriptional suppression), demonstrating two independent mechanisms for Kv4.3 downregulation in cardiac hypertrophy.\",\n      \"method\": \"RNase protection assays, immunoblot, mRNA turnover measurements, Kv4.3 5'-flanking region cloning and promoter-reporter assays in neonatal rat cardiac myocytes\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (mRNA stability, promoter-reporter) distinguishing two independent regulatory mechanisms, replicated in same study\",\n      \"pmids\": [\"11249870\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"KChIP2 splice variants (KChIP2S, KChIP2T, and a previously described isoform) each increase Kv4.3 current density, slow inactivation in a Ca2+-dependent manner, and hasten recovery from inactivation in a splice-variant-specific fashion. KChIP2 expression is graded transmurally in human and canine left ventricle.\",\n      \"method\": \"Kinetic RT-PCR, Western blot, immunocytochemistry, whole-cell patch clamp with co-expression in heterologous cells\",\n      \"journal\": \"Circulation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (biochemical + electrophysiology), single lab\",\n      \"pmids\": [\"12135940\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"KChIP2 palmitoylation at N-terminal cysteines is required for efficient plasma membrane localization of Kv4.3 channels. Longer KChIP2 isoforms containing a 32-amino acid N-terminal peptide with palmitoylation sites produce larger increases in Kv4.3 protein level and current density; mutating these cysteines reduces membrane localization and current enhancement.\",\n      \"method\": \"Metabolic labeling for palmitoylation, mutagenesis of palmitoylation cysteines, confocal immunofluorescence, whole-cell patch clamp in heterologous cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — metabolic labeling demonstrating PTM, mutagenesis showing functional consequence, subcellular localization experiments, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"12006572\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"A structurally minimal KChIP2 isoform (KChIP2d, C-terminal 70 amino acids with one EF-hand) is sufficient to accelerate Kv4.3 recovery from inactivation and slow inactivation kinetics. The EF-hand modulates inactivation but not recovery; Ca2+-independent recovery effects map to a stretch of amino acids outside the EF-hand.\",\n      \"method\": \"Cloning of KChIP2d from ferret heart, co-expression with Kv4.3 in Xenopus oocytes, whole-cell patch clamp, mutagenesis of EF-hand\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — domain deletion and mutagenesis with electrophysiological readout, single lab with multiple constructs\",\n      \"pmids\": [\"12433945\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Kv4.3 exhibits C-type (outer pore collapse) inactivation: removal of external K+ accelerates inactivation and promotes cumulative inactivation by repetitive stimulation. This is consistent with K+ occupancy of a selectivity filter site that stabilizes the conducting state.\",\n      \"method\": \"Whole-cell voltage-clamp with varied external K+ concentrations and ion substitution experiments in HEK cells expressing Kv4.3\",\n      \"journal\": \"The Journal of membrane biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — single lab, rigorous in vitro analysis but single method approach\",\n      \"pmids\": [\"12172648\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"CaMKII directly phosphorylates Kv4.3 at S550 in the C-terminal region, slowing inactivation and accelerating recovery from inactivation. The S550A mutation renders Kv4.3 insensitive to both CaMKII dialysis and CaMKII inhibitory peptide, identifying S550 as the functionally critical phosphorylation site.\",\n      \"method\": \"Whole-cell patch clamp with intrapipette delivery of autothiophosphorylated CaMKII or inhibitory peptides, site-directed mutagenesis of consensus CaMKII phosphorylation sites in Kv4.3\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis identifying specific phosphorylation site combined with pharmacological and biochemical manipulation, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"15456698\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Angiotensin receptor type 1 (AT1R) forms a physical complex with Kv4.3: co-immunoprecipitation from canine ventricle and from HEK293 cells co-expressing AT1R, Kv4.3, and KChIP2. FRET demonstrates close spatial proximity. Ang II stimulation internalizes Kv4.3 together with AT1R and shifts activation voltage threshold of remaining surface Kv4.3 to more positive values.\",\n      \"method\": \"Co-immunoprecipitation from native canine ventricle and HEK293 cells, FRET with CFP/YFP-tagged proteins, live-cell confocal imaging, whole-cell patch clamp\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal co-IP in native tissue confirmed by FRET and functional electrophysiology, multiple orthogonal methods in one study\",\n      \"pmids\": [\"15342638\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"KChIP2b and KChIP2d modulate Kv4.3 gating by accelerating recovery from inactivation (acting on closed-state inactivation transitions), slowing closed-state inactivation, and promoting open-state inactivation. Ca2+-dependent effects on inactivation are mediated through open-state (not closed-state) inactivation mechanisms.\",\n      \"method\": \"Kinetic analysis of macroscopic currents in Xenopus oocytes co-expressing Kv4.3 with KChIP2 isoforms, multi-state kinetic modeling\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — comprehensive kinetic analysis with model validation, two KChIP2 isoforms compared, single lab\",\n      \"pmids\": [\"14724186\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"In vivo adenoviral Kv4.3 gene transfer in rats subjected to aortic stenosis increased Ito density, shortened APD50, and abrogated cardiac hypertrophy. This was associated with significant reductions in calcineurin and NFATc1 expression, linking Kv4.3-mediated Ito to the calcineurin/NFAT hypertrophic pathway.\",\n      \"method\": \"In vivo adenoviral gene transfer, whole-cell patch clamp, immunoblot for calcineurin and NFATc1, heart weight/body weight ratio, cellular capacitance measurements\",\n      \"journal\": \"Circulation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo gain-of-function with defined molecular pathway (calcineurin/NFAT) linked to electrophysiological and hypertrophic phenotypes, single lab multiple methods\",\n      \"pmids\": [\"15557376\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"DPPX (DPP6) co-expressed with Kv4.3 in CHO cells accelerates inactivation and recovery from inactivation; co-expression of DPPX together with KChIP2a and Kv4.3 produces current kinetics matching native human ventricular Ito. DPPX protein is detected in human but not rat ventricle by specific antibody, establishing it as an essential component of the native human cardiac Ito channel complex.\",\n      \"method\": \"Quantitative real-time RT-PCR, Western blot, co-expression in CHO cells, whole-cell patch clamp comparison to native human ventricular Ito\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional reconstitution in CHO cells with comparison to native current, protein-level validation in human tissue, single lab multiple methods\",\n      \"pmids\": [\"15890703\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Ang II activates AT1 receptors to destabilize Kv4.3 channel mRNA via the 3'UTR through NADPH oxidase-derived superoxide acting on the ASK1-p38 kinase pathway. Mechanical stretch also downregulates Kv4.3 3'UTR reporter activity requiring AT1 receptors and NADPH oxidase. The effect is specific: Kv4.2 and Kv1.5 3'-UTR sequences are insensitive to Ang II.\",\n      \"method\": \"3'UTR-reporter mRNA and activity assays in neonatal rat ventricular myocytes, dominant-negative rac, NADPH oxidase inhibitors, SOD/catalase overexpression, ASK1-p38 pathway inhibitors, stretch experiments\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal genetic and pharmacological tools defining the pathway, confirmed for both chemical and mechanical stimuli, single lab\",\n      \"pmids\": [\"16556864\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"CaMKII co-immunoprecipitates with Kv4.3 channels in rat ventricular myocytes without requiring Ca2+ elevation (basal association), whereas CaMKII association with Kv4.2 requires Ca2+ increase. Inhibition of CaMKII specifically accelerates Kv4.3 inactivation. Kv4.3 thus serves as a molecular scaffold concentrating CaMKII at the membrane, allowing localized Ca2+-dependent regulation of associated Kv4.2 channels.\",\n      \"method\": \"Co-immunoprecipitation from rat ventricular myocytes, Western blot phosphorylation analysis, whole-cell patch clamp with CaMKII inhibitors in HEK cells transfected with Kv4.2 or Kv4.3\",\n      \"journal\": \"American journal of physiology. Heart and circulatory physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal co-IP from native tissue plus electrophysiology, distinguishing Kv4.2 vs Kv4.3 CaMKII dependence with multiple methods\",\n      \"pmids\": [\"16648177\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"DPP10, another dipeptidyl peptidase-related subunit, modulates Kv4.3 inactivation primarily by affecting closed-state inactivation and causing negative shifts in steady-state activation and inactivation. When co-expressed with both Kv4.3 and KChIP2b, the effects of DPP10 on steady-state properties are abolished, while closed-state inactivation differences remain, demonstrating that DPP10 and KChIP2b modulate distinct inactivation states.\",\n      \"method\": \"Heterologous co-expression in CHO or HEK cells, whole-cell patch clamp, comparison of Kv4.3 alone, Kv4.3+KChIP2b, Kv4.3+DPP10, and triple combinations; truncation mutant of DPP10\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — systematic co-expression with multiple subunit combinations and truncation mutant identifying transmembrane domain sufficiency, single lab\",\n      \"pmids\": [\"16738002\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Kv4.3 mediates A-type K+ currents underlying subthreshold membrane potential oscillations (MPOs) in hippocampal CA1 LM/RAD interneurons. siRNA knockdown of Kv4.3 selectively impaired A-type K+ currents and abolished MPOs in these specific interneuron subpopulations.\",\n      \"method\": \"siRNA knockdown, whole-cell patch clamp in hippocampal interneurons in acute slices, immunocytochemistry for Kv4.3\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-specific siRNA knockdown with defined electrophysiological phenotype (loss of MPOs), single lab with immunocytochemistry confirmation\",\n      \"pmids\": [\"17314290\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Genetic deletion of Kv4.3 (KCND3-/-) in mice does not eliminate ventricular Ito,f: functional Ito,f channels are expressed at normal density in Kv4.3-/- myocytes with unchanged properties, indicating Kv4.3 is not required for mouse ventricular Ito,f channel generation (in contrast to Kv4.2).\",\n      \"method\": \"Targeted gene disruption (Kv4.3-/- mice), whole-cell voltage clamp, quantitative RT-PCR, Western blot\",\n      \"journal\": \"Journal of molecular and cellular cardiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean knockout with multiple validation methods (electrophysiology + biochemistry), negative finding well-controlled\",\n      \"pmids\": [\"18045613\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"KChIP4a has a crystal structure (3.0 Å resolution) showing distinct N-terminal α-helices. Competitive binding of the Kv4.3 N-terminal peptide to the hydrophobic groove of KChIP4a core displaces the KChIP4a N-terminus; this released N-terminus serves as a slow inactivation gate for Kv4.3. The first N-terminal α-helix of KChIP4a (residues 1–34) is sufficient to confer slow inactivation when fused to N-terminally truncated Kv4.3.\",\n      \"method\": \"X-ray crystallography (3.0 Å), biochemical competition binding, electrophysiology with N-terminal peptide application and chimeric channel constructs\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structure combined with biochemical and electrophysiological validation of mechanism, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"19109250\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"AUF1 (ARE/poly-(U)-binding/degradation factor 1) is upregulated by Ang II through AT1R-NADPH oxidase-p38 MAPK signaling. Elevated AUF1 binds to an AU-rich element (ARE) in the Kv4.3 3'UTR, destabilizing the mRNA. AUF1 overexpression mimics the Ang II effect, AUF1 siRNA blocks it, and pull-down assays confirm increased AUF1 binding to the Kv4.3 ARE after Ang II treatment.\",\n      \"method\": \"3'UTR deletion and mutagenesis analysis, AUF1 overexpression and siRNA knockdown, RNA pull-down assays, reporter mRNA stability assays in neonatal rat ventricular myocytes\",\n      \"journal\": \"Journal of molecular and cellular cardiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ARE identified by mutagenesis, AUF1 confirmed as effector by both overexpression and knockdown, direct RNA-protein interaction by pull-down, single lab multiple orthogonal methods\",\n      \"pmids\": [\"18789946\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"NRSF (neuron-restrictive silencer factor) binds directly to the NRSE in the Kv4.3 gene promoter after peripheral nerve injury, causing epigenetic silencing: ChIP assay shows increased NRSF binding and markedly reduced acetylation of histone H4 (but not H3) at the Kv4.3-NRSE in dorsal root ganglion. Antisense knockdown of NRSF blocks the injury-induced Kv4.3 downregulation.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP) for NRSF binding and histone acetylation, antisense NRSF knockdown in rat dorsal root ganglion after sciatic nerve injury, RT-PCR\",\n      \"journal\": \"Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP identifies specific epigenetic mechanism plus knockdown confirms functional relevance, single lab two orthogonal methods\",\n      \"pmids\": [\"20006971\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"KCNE2 co-expression with Kv4.3 reduces peak current density, slows inactivation, and causes a positive shift of steady-state inactivation, rendering Kv4.3 more similar to native cardiac Ito. KCNE2 variants M54T and I57T produce gain-of-function effects (increased current density, slowed inactivation, faster recovery) compared to wild-type KCNE2.\",\n      \"method\": \"Co-expression of Kv4.3 with KCNE2 WT or variants in heterologous cells, whole-cell patch clamp\",\n      \"journal\": \"Heart rhythm\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — single lab, single electrophysiological method comparing WT and variant subunit effects\",\n      \"pmids\": [\"20042375\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"The S3b region of Kv4.3 (residues L275 and V276) constitutes the binding site for the gating modifier toxin HpTx2; alanine scanning shows that simultaneous mutation of L275A and V276A nearly eliminates toxin interaction. KChIP2b co-expression increases HpTx2 affinity for Kv4.3, attributed to KChIP2b-induced stabilization of the closed state.\",\n      \"method\": \"Alanine-scanning mutagenesis of Kv4.3 S3b, electrophysiological concentration-response analysis in Xenopus oocytes, KChIP2b co-expression\",\n      \"journal\": \"Molecular pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — systematic alanine scanning with functional readout identifying binding determinants, single lab\",\n      \"pmids\": [\"19357248\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"PKC isoform-specific regulation: PKCα plays the central role in PKC-dependent downregulation of Kv4.3 current. PMA and conventional PKC activator TMX reduced Kv4.3 current; these effects were abolished by PKCα inhibition (HBDDE) or PKCα siRNA but not by PKCβ inhibition or siRNA. PKCα activator iripallidal mimicked the effect on Kv4.3.\",\n      \"method\": \"Xenopus oocyte two-electrode voltage clamp, PKC isoform-selective inhibitors/activators, siRNA knockdown of PKCα vs PKCβ, native rat cardiomyocyte patch clamp\",\n      \"journal\": \"Journal of molecular and cellular cardiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological and genetic (siRNA) approaches converge on PKCα, confirmed in native cardiomyocytes, single lab multiple methods\",\n      \"pmids\": [\"21803046\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Closed-state inactivation (CSI) of Kv4.3 is differentially regulated by PKC in the two splice isoforms. PMA (PKC activator) reduces CSI magnitude in Kv4.3-short but increases CSI in Kv4.3-long. This isoform-specific difference maps to T504, a PKC phosphorylation site unique to the long isoform; T504D mutation eliminates the PMA response.\",\n      \"method\": \"Xenopus oocyte expression, whole-cell voltage clamp, PMA and purified PKC application, site-directed mutagenesis of T504\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis identifying specific phosphorylation site with electrophysiological validation, single lab with multiple perturbation approaches\",\n      \"pmids\": [\"19675305\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"A dynamic Kv4.3-CaMKII complex is present at the plasma membrane of cardiomyocytes (co-IP and FRET). CaMKII dissociation from this complex increases CaMKII autophosphorylation and L-type Ca2+ current facilitation. Kv4.3 overexpression reduces basal CaMKII autophosphorylation and eliminates Ca2+-induced CaMKII activation by binding to the calmodulin binding sites of CaMKII.\",\n      \"method\": \"Co-immunoprecipitation from cardiomyocytes, FRET (CFP/YFP), overexpression of Kv4.3, BAPTA vs EGTA Ca2+ chelation, whole-cell patch clamp for L-type Ca2+ current\",\n      \"journal\": \"European heart journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — co-IP confirmed by FRET, gain-of-function with mechanistic dissection (calmodulin binding site), multiple orthogonal methods, single lab\",\n      \"pmids\": [\"21148163\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Kv4.2 and Kv4.3, along with Kv1.4, encode distinct components of the macroscopic IA in mouse cortical pyramidal neurons. Genetic deletion of Kv4.2 and Kv4.3 (double knockout) reveals a residual Kv1.4-encoded component; Kv4.3 encodes the larger component in neurons lacking both Kv4.2 and Kv1.4, and deletion of individual subunits causes subunit-specific electrical remodeling.\",\n      \"method\": \"Single and double knockout mouse models (Kv4.2-/-, Kv4.3-/-, Kv4.2-/-/Kv4.3-/-), whole-cell patch clamp in cortical pyramidal neurons, 4-AP pharmacology\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic dissection with double knockout and pharmacology, replicated across multiple genotypes\",\n      \"pmids\": [\"20371829\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Nitric oxide (NO) inhibits Kv4.3 current (IC50 ~375 nM) through activation of adenylate cyclase → cAMP-dependent protein kinase (PKA) → serine-threonine phosphatase 2A signaling cascade. This inhibition prolongs the plateau of mouse atrial action potential.\",\n      \"method\": \"Whole-cell patch clamp in CHO cells expressing Kv4.3 and in isolated human atrial and mouse ventricular myocytes, NO donors, adenylate cyclase and PKA modulators, phosphatase inhibitors\",\n      \"journal\": \"Cardiovascular research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pathway identified using pharmacological tools in both heterologous cells and native myocytes, single lab\",\n      \"pmids\": [\"18678642\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"KCND3 gain-of-function mutations L450F and G600R (found in Brugada syndrome patients) increase peak Ito current density by 146% and 50% respectively when co-expressed with KChIP2 in HEK293 cells, establishing a gain-of-function mechanism for these mutations in Brugada syndrome pathogenesis.\",\n      \"method\": \"Site-directed mutagenesis, co-expression with KChIP2 in HEK293 cells, whole-cell patch clamp, Luo-Rudy AP model simulation\",\n      \"journal\": \"Heart rhythm\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct electrophysiological characterization of engineered mutations with simulation validation, single lab multiple methods\",\n      \"pmids\": [\"21349352\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"KCND3 mutations cause SCA19/22: p.F227del mutant Kv4.3 is retained in the cytoplasm (loss of plasma membrane localization) with absent A-type K+ channel conductance in patch clamp. p.G345V and p.T377M mutations also identified as pathogenic, confirming KCND3 as the SCA19/22 gene across multiple ethnic groups.\",\n      \"method\": \"Whole exome sequencing, Sanger sequencing, immunofluorescence localization in heterologous cells, whole-cell patch clamp\",\n      \"journal\": \"Annals of neurology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — loss-of-function established by both subcellular localization (ER retention) and electrophysiology, replicated across multiple mutations and ethnic families\",\n      \"pmids\": [\"23280837\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"SCA19 (KCND3) mutations T352P, M373I, and S390N cause Kv4.3 retention in the endoplasmic reticulum and enhanced protein instability. KChIP2 rescues membrane localization and stability of two of three mutants but does not fully restore channel function. T352P Purkinje cells show intracellular Kv4.3 accumulation with reduced protein levels in autopsy material.\",\n      \"method\": \"Exome sequencing, HeLa cell ectopic expression, immunofluorescence, whole-cell patch clamp, SCA19 cerebellar autopsy immunohistochemistry, KChIP2 rescue co-expression\",\n      \"journal\": \"Annals of neurology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — human autopsy confirmation + in vitro electrophysiology + subcellular localization + KChIP2 rescue experiment, multiple orthogonal methods\",\n      \"pmids\": [\"23280838\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"KCND3 gain-of-function mutation A545P in Kv4.3 (found in early-onset lone AF patient) increases peak current density and slows inactivation compared to WT, both in the absence and presence of KChIP2, constituting a gain-of-function associated with atrial fibrillation.\",\n      \"method\": \"Direct sequencing of KCND3 in AF patients, co-expression in CHO-K1 cells with or without KChIP2, whole-cell patch clamp\",\n      \"journal\": \"Cardiovascular research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — single patient mutation characterized electrophysiologically, single lab single method\",\n      \"pmids\": [\"23400760\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"SEMA3A (semaphorin 3A) is a naturally occurring protein inhibitor that selectively reduces Kv4.3 peak current density without altering cell surface expression. Co-immunoprecipitation and disruption of a hanatoxin-like binding domain on Kv4.3 indicate a direct protein-protein interaction. SEMA3A mutations found in Brugada syndrome disrupt SEMA3A's ability to inhibit Kv4.3, resulting in gain-of-function.\",\n      \"method\": \"Co-expression in HEK293 cells with whole-cell patch clamp, co-immunoprecipitation, disruption of putative toxin-binding domain on Kv4.3, SEMA3A perfusion, iPSC-cardiomyocyte assays\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (co-IP, domain disruption mutagenesis, iPSC-CMs, heterologous cell perfusion) establishing direct interaction and functional consequence\",\n      \"pmids\": [\"24963029\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"NS5806 (Kv4.3 current activator) binds at a hydrophobic site on the C-terminus of KChIP3 in a Ca2+-dependent manner (Kd 2–5 µM in Ca2+-bound form). NS5806 increases affinity between KChIP3 and the N-terminus of Kv4.3 and decreases the dissociation rate. Tyr-174 and Phe-218 on KChIP3 are required for this enhancement.\",\n      \"method\": \"Fluorescence spectroscopy, isothermal calorimetry, docking simulations, mutagenesis of KChIP3 residues\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct biophysical binding measurements (ITC + fluorescence) with mutagenesis confirmation, single lab multiple orthogonal methods\",\n      \"pmids\": [\"25228688\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"SCA19/22-mutant Kv4.3 subunits exert a dominant-negative effect on WT Kv4.3 trafficking and surface expression in the absence of KChIP2; KChIP2 can rescue this dominant-negative effect. All SCA19/22 mutants either suppress WT Kv4.3 current amplitude or alter channel gating in a dominant manner.\",\n      \"method\": \"Co-expression of mutant and WT Kv4.3 in heterologous cells, surface expression assays, whole-cell patch clamp, KChIP2 rescue co-expression\",\n      \"journal\": \"Cellular and molecular life sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — dominant-negative mechanism demonstrated by co-expression with WT plus KChIP2 rescue, single lab multiple constructs\",\n      \"pmids\": [\"25854634\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"A de novo KCND3 mutation (p.Arg293_Phe295dup) duplicating the RVF motif in the voltage-sensor domain causes a severe shift of voltage-dependence of gating to more depolarized voltages, demonstrating that addition of an extra positive charge to the S4 voltage sensor profoundly impairs Kv4.3 channel function.\",\n      \"method\": \"Whole exome sequencing, immunocytochemistry, immunoblot, whole-cell patch clamp\",\n      \"journal\": \"BMC medical genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — single de novo mutation with electrophysiological characterization, single lab, single patient\",\n      \"pmids\": [\"26189493\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Ang II acting via AT1R-ROS-p38 MAPK signaling downregulates Kv4.3 mRNA and protein expression and decreases A-type K+ current in CATH.a neurons. This mechanism contributes to Kv4.3 downregulation in the RVLM of chronic heart failure rats, leading to neuronal hyperexcitability and sympathoexcitation.\",\n      \"method\": \"Rat Genome GeneChip array, real-time RT-PCR, Western blot, whole-cell patch clamp in CATH.a cells, Tempol (superoxide scavenger) and SB-203580 (p38 inhibitor) pharmacology, RVLM microinjection of 4-AP\",\n      \"journal\": \"American journal of physiology. Heart and circulatory physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pathway confirmed by pharmacological inhibitors in neuronal cell line with in vivo correlation, single lab\",\n      \"pmids\": [\"20044444\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Thyroid hormone receptors TRα1 and TRβ1 divergently regulate KCND3 transcription: TRα1 activates and TRβ1 suppresses KCND3 promoter activity. Deletion and mutagenesis mapping identified the TRα1 response element at −1651 bp (G-1651T abolishes activation) and the TRβ1 response element at −73 bp (G-73T abolishes suppression) of the KCND3 transcription start site.\",\n      \"method\": \"Adenoviral overexpression of TRα1/TRβ1 in rat cardiomyocytes, KCND3 5'-flanking reporter constructs, deletion analysis, site-directed mutagenesis of TR binding sites, patch clamp\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — promoter-reporter analysis with deletion mapping and mutagenesis confirming specific TR binding sites, functional electrophysiology validation, single lab\",\n      \"pmids\": [\"19171649\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Large T-antigen increases Kv4.3 expression through upregulation of transcription factor Sp1; Sp1 decoy oligonucleotide reduces Kv4.3 expression in HEK-293T cells, and Sp1 overexpression increases Kv4.3 in HEK-293 cells. Inhibition of Kv4.3 (by 4-AP or siRNA) induces cell apoptosis and necrosis that is rescued by the CaMKII inhibitor KN-93, placing Kv4.3 upstream of CaMKII-mediated cell death.\",\n      \"method\": \"Sp1 decoy oligonucleotide, Sp1 overexpression vector, siRNA knockdown of Kv4.3, 4-AP pharmacology, cell viability/death assays, KN-93 rescue\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Sp1-dependent transcription confirmed by gain and loss of function; CaMKII-apoptosis link via pharmacological rescue, single lab\",\n      \"pmids\": [\"22023388\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Kv4.3 expression in nociceptive-like TG neurons is downregulated following infraorbital nerve chronic constrictive injury (ION-CCI), reducing IA currents and increasing neuronal excitability. Pharmacological inhibition of Kv4.3 with phrixotoxin-2 reproduced cold hypersensitivity; pharmacological potentiation of Kv4.3 amplified IA and alleviated cold hypersensitivity.\",\n      \"method\": \"Immunostaining, whole-cell patch clamp in dissociated TG neurons, orofacial operant behavioral test, phrixotoxin-2 injection and Kv4.3 activator application in ION-CCI rats\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — bidirectional pharmacological manipulation of Kv4.3 with behavioral and electrophysiological readouts in injury model, single lab\",\n      \"pmids\": [\"33472822\", \"29313436\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Novel SCA19/22-associated KCND3 mutations (C317Y, P375S, V338E, T377M) all exhibit loss-of-function phenotypes: reduced current amplitudes, enhanced protein degradation, and defective membrane trafficking in heterologous expression. Co-expression of mutant and WT Kv4.3 demonstrates dominant-negative effects on protein biosynthesis and voltage-dependent gating of WT channels.\",\n      \"method\": \"In vitro heterologous expression, whole-cell patch clamp, protein biochemistry (Western blot for degradation), immunofluorescence for membrane trafficking, co-expression of mutant+WT\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple mutations characterized by electrophysiology, biochemistry, and localization in one study demonstrating dominant-negative mechanism, single lab\",\n      \"pmids\": [\"31293010\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"De novo KCND3 mutation G306A (Gly306Ala) associated with early repolarization syndrome produces gain-of-function: increased current density, slow inactivation, and slow recovery from inactivation compared to WT. Quinidine restores inactivation kinetics of mutant Kv4.3, consistent with its clinical efficacy in the patient.\",\n      \"method\": \"Whole exome sequencing, whole-cell patch clamp in cultured cells, action potential simulation\",\n      \"journal\": \"Heart rhythm\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — single de novo mutation with electrophysiology and drug response, single patient and lab\",\n      \"pmids\": [\"31173922\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Alternative isoforms of Kv4 auxiliary subunits (KChIP1 vs KChIP4e and DPP6S) expressed in different CCK+ interneurons determine their firing phenotype. Neurons expressing KChIP4e and DPP6S with Kv4.3 display distinct low-voltage-activated K+ currents and a previously undetected membrane potential-dependent firing phenotype, while neurons with KChIP1 fire regularly, demonstrating that auxiliary subunit isoform identity specifies neuronal excitability.\",\n      \"method\": \"Whole-cell patch clamp in rat hippocampal CA3 slices, single-cell transcriptomics (gene profiling), immunofluorescence, pharmacology\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — correlation of auxiliary subunit isoforms with firing phenotype confirmed by multiple methods, but causal direction primarily inferred from natural variation rather than direct manipulation\",\n      \"pmids\": [\"32490811\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"The miR-27a-3p/Hoxa10/Kv4.3 axis mediates Ang II-induced cardiomyocyte hypertrophy: miR-27a-3p targets the 3'UTR of Hoxa10 (confirmed by luciferase assay), reducing Hoxa10 protein; Hoxa10 overexpression reverses hypertrophy and electrical remodeling and positively regulates Kv4.3 expression.\",\n      \"method\": \"Ang II-induced cardiomyocyte hypertrophy model, luciferase reporter assay for miR-27a-3p targeting of Hoxa10 3'UTR, miR-27a-3p inhibitor, Hoxa10 overexpression, Western blot, RT-PCR\",\n      \"journal\": \"Frontiers in pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — luciferase assay confirms direct miRNA-3'UTR interaction; overexpression rescue links Hoxa10 to Kv4.3, single lab\",\n      \"pmids\": [\"34248630\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Acacetin (natural flavone) inhibits KCND3-encoded Kv4.3 WT with IC50 of 7.2 µM. KCND3-V392I gain-of-function mutation increases Ito by 92% in HEK cells and 61% in patient-derived iPSC-CMs; 30 µM acacetin inhibited V392I peak Ito by 96% and abolished the accentuated action potential notch in V392I iPSC-CMs.\",\n      \"method\": \"Site-directed mutagenesis, whole-cell patch clamp in TSA201 cells, gene-edited isogenic and patient-specific iPSC-CMs with multielectrode array and patch clamp, Western blot, immunocytochemistry\",\n      \"journal\": \"Circulation. Genomic and precision medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — mutant characterized in heterologous cells and validated in iPSC-CMs with isogenic controls; pharmacological rescue demonstrated at multiple levels (current and action potential), single lab multiple orthogonal methods\",\n      \"pmids\": [\"35861988\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"KCND3-encoded Kv4.3 is a voltage-gated, rapidly inactivating A-type K+ channel that serves as the primary pore-forming subunit of the cardiac transient outward current (Ito) and neuronal IA current; it forms macromolecular complexes with auxiliary subunits (KChIP1-4, DPPX/DPP6, DPP10, KvB2, KCNE2) that control plasma membrane trafficking, inactivation gating kinetics, and current density. Kv4.3 gating is regulated by direct phosphorylation at S550 by CaMKII (slowing inactivation) and isoform-specifically by PKCα (reducing current) and PKC via T504 (isoform-specific closed-state inactivation modulation). The channel also physically associates with AT1R (mediating angiotensin II-induced internalization) and sequesters inactive CaMKII at the membrane to suppress its activation. At the transcriptional/post-transcriptional level, Kv4.3 expression is reduced by angiotensin II (via NADPH oxidase-p38 MAPK-AUF1-mediated mRNA destabilization through the 3'UTR ARE), by phenylephrine (via promoter suppression), and by NRSF-mediated epigenetic silencing (histone H4 deacetylation) after nerve injury; TRα1 activates and TRβ1 suppresses KCND3 transcription through distinct promoter elements. Loss-of-function KCND3 mutations cause SCA19/22 through ER retention, protein instability, and dominant-negative suppression of WT channel function, while gain-of-function mutations underlie Brugada syndrome, early repolarization syndrome, and atrial fibrillation through enhanced Ito. In neurons, Kv4.3 underlies subthreshold membrane potential oscillations in specific hippocampal interneurons and A-type currents in nociceptive trigeminal ganglion neurons, where its downregulation contributes to neuropathic pain.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"KCND3 encodes Kv4.3, the pore-forming subunit of a rapidly inactivating, voltage-gated A-type K+ channel that constitutes the principal molecular correlate of the cardiac transient outward current (Ito) and contributes to neuronal A-type currents (IA) [#0, #29]. In the heart, Kv4.3-mediated Ito sets the action potential plateau and duration: overexpression abbreviates APD while dominant-negative suppression prolongs APD and the QT interval, and increased Ito antagonizes calcineurin/NFAT-driven hypertrophy [#4, #14]. Kv4.3 functions within a macromolecular complex whose biophysics are tuned by auxiliary subunits — KChIP isoforms increase current density, slow inactivation in a Ca2+-dependent manner, and accelerate recovery from inactivation, with KChIP-mediated palmitoylation and N-terminal interactions controlling membrane trafficking and acting as a slow inactivation gate, while dipeptidyl-peptidase-related subunits DPP6/DPPX and DPP10 and the KCNE2 and Kvβ subunits further shape inactivation gating and reconstitute native human Ito kinetics [#7, #8, #21, #15, #18, #3, #24]. Channel gating is regulated by direct phosphorylation: CaMKII phosphorylates S550 to slow inactivation, and PKCα downregulates current while a long-isoform-specific T504 site governs PKC modulation of closed-state inactivation [#11, #26, #27]. Kv4.3 also physically associates with the angiotensin II type-1 receptor, which drives Ang II-induced channel internalization, and sequesters inactive CaMKII at the membrane to suppress its autophosphorylation and downstream L-type Ca2+ current facilitation [#12, #28]. Kv4.3 abundance is controlled at multiple levels — Ang II destabilizes its mRNA through an AT1R/NADPH-oxidase/p38/AUF1 pathway acting on a 3'UTR AU-rich element, phenylephrine suppresses its promoter, NRSF epigenetically silences the gene via histone H4 deacetylation after nerve injury, and thyroid hormone receptors TRα1 and TRβ1 oppositely regulate its transcription [#6, #16, #22, #23, #40]. Loss-of-function KCND3 mutations cause SCA19/22 through ER retention, protein instability, and dominant-negative suppression of wild-type channels, whereas gain-of-function mutations underlie Brugada syndrome, early repolarization syndrome, and atrial fibrillation by enhancing Ito [#32, #33, #37, #43, #31, #44, #34]. In neurons, Kv4.3 underlies subthreshold membrane potential oscillations in hippocampal interneurons and A-type currents in nociceptive trigeminal neurons whose downregulation drives neuropathic cold hypersensitivity [#19, #42].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Establishing the molecular identity of cardiac Ito was the foundational question; demonstrating that heterologous Kv4.3 reproduces the biophysics and pharmacology of native Ito identified the pore-forming subunit of this repolarizing current.\",\n      \"evidence\": \"Heterologous expression in oocytes/HEK with patch clamp and in situ hybridization across canine, human, and rat heart\",\n      \"pmids\": [\"8831489\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not address auxiliary subunit requirements for native current\", \"Human-specific complex composition not resolved\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Whether tissue-specific Kv4.3 isoforms differ functionally was unknown; cloning long and short variants showed a 19-amino-acid insertion shifts inactivation voltage dependence, explaining tissue-specific gating and window current differences.\",\n      \"evidence\": \"RT-PCR cloning and heterologous expression with patch clamp in oocytes and HEK cells (rat and human)\",\n      \"pmids\": [\"9450548\", \"10200233\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological consequence of isoform choice in vivo not established at this stage\", \"Regulatory basis of tissue-specific splicing unknown\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"How native Ito kinetics arise from Kv4.3 alone was unresolved; KChIP2 subunits were shown to increase current density and tune inactivation/recovery in Ca2+-dependent and splice-variant-specific ways, with palmitoylation controlling membrane localization.\",\n      \"evidence\": \"Co-expression with KChIP2 isoforms, metabolic labeling for palmitoylation, mutagenesis, confocal imaging, and patch clamp\",\n      \"pmids\": [\"12135940\", \"12006572\", \"12433945\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry of the channel-KChIP complex not defined\", \"Structural basis of the interaction not yet resolved\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Whether Ito causally controls cardiac repolarization in vivo was untested; gain- and loss-of-function gene transfer demonstrated that Kv4.3-mediated Ito sets plateau potential and APD and modulates QT.\",\n      \"evidence\": \"In vivo adenoviral Kv4.3 overexpression and dominant-negative W362F transfer with myocyte patch clamp and ECG\",\n      \"pmids\": [\"10772652\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Species-specific Ito subunit dependence not addressed\", \"Link to hypertrophy not yet made\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"The mechanism of Kv4.3 downregulation in hypertrophy was unknown; Ang II and phenylephrine were shown to act through distinct pathways — mRNA destabilization versus promoter suppression respectively.\",\n      \"evidence\": \"RNase protection, mRNA turnover, and promoter-reporter assays in neonatal rat cardiac myocytes\",\n      \"pmids\": [\"11249870\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the mRNA-destabilizing factor not yet known\", \"Promoter elements targeted by PE not mapped\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"How Kv4.3 gating is regulated by signaling was open; CaMKII was shown to directly phosphorylate S550 to slow inactivation and accelerate recovery, while AT1R was found to physically complex with Kv4.3 and mediate Ang II-induced internalization.\",\n      \"evidence\": \"Site-directed mutagenesis with CaMKII dialysis/inhibitory peptides; co-IP from canine ventricle plus FRET and patch clamp\",\n      \"pmids\": [\"15456698\", \"15342638\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Phosphatase counter-regulation not defined\", \"Trafficking machinery of AT1R-driven internalization unresolved\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"What additional subunits reconstitute native human Ito was unresolved; DPPX/DPP6 was shown to be required, and combined with KChIP2a yields current matching native human ventricular Ito, with DPP6 protein present in human but not rat ventricle.\",\n      \"evidence\": \"qRT-PCR, Western blot, CHO co-expression, and patch clamp comparison to native human Ito\",\n      \"pmids\": [\"15890703\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full subunit stoichiometry of the native complex not resolved\", \"Species differences in complex composition incompletely mapped\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"The molecular effector destabilizing Kv4.3 mRNA and the role of Kv4.3 as a CaMKII scaffold were defined; AUF1 acting on a 3'UTR ARE downstream of AT1R/NADPH-oxidase/p38 mediates mRNA decay, and Kv4.3 basally binds CaMKII to concentrate it at the membrane.\",\n      \"evidence\": \"3'UTR reporter/mutagenesis with AUF1 overexpression/knockdown and RNA pull-down; co-IP from ventricular myocytes with patch clamp\",\n      \"pmids\": [\"16556864\", \"16648177\", \"18789946\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo contribution of AUF1 to disease remodeling not established\", \"Dynamic regulation of CaMKII sequestration not fully resolved\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Whether Kv4.3 is essential for native A-type currents was tested genetically; Kv4.3 knockout did not eliminate mouse ventricular Ito,f but selectively contributes to neuronal A-type currents underlying subthreshold oscillations.\",\n      \"evidence\": \"Kv4.3-/- mice with patch clamp and biochemistry; siRNA knockdown in hippocampal interneurons in acute slices\",\n      \"pmids\": [\"18045613\", \"17314290\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional redundancy with Kv4.2 in heart not fully dissected\", \"Neuronal versus cardiac subunit dependence differs and is incompletely explained\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"The structural basis of KChIP modulation was unknown; the KChIP4a crystal structure with competitive Kv4.3 N-terminal peptide binding revealed a released KChIP N-terminus acting as a slow inactivation gate.\",\n      \"evidence\": \"X-ray crystallography (3.0 Å), competition binding, and chimeric channel electrophysiology\",\n      \"pmids\": [\"19109250\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full assembled channel-KChIP structure not solved\", \"Generalizability across all KChIP isoforms not established\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Multiple layers of Kv4.3 regulation were dissected: isoform-specific PKC modulation via T504 and PKCα-dependent current reduction, divergent thyroid-hormone-receptor transcriptional control, additional subunits (KCNE2, DPP10), toxin binding sites, and NRSF-mediated epigenetic silencing after nerve injury.\",\n      \"evidence\": \"Mutagenesis with PKC application, promoter-reporter/deletion mapping, co-expression electrophysiology, alanine scanning, and ChIP with NRSF knockdown\",\n      \"pmids\": [\"19675305\", \"21803046\", \"19171649\", \"20042375\", \"16738002\", \"19357248\", \"20006971\", \"20044444\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Integration of competing transcriptional inputs in vivo unclear\", \"Crosstalk among the multiple regulatory pathways not modeled\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"The functional consequence of the Kv4.3-CaMKII complex and the neuronal subunit hierarchy were clarified; Kv4.3 binds CaMKII calmodulin sites to suppress its autophosphorylation and L-type Ca2+ current facilitation, and genetic dissection placed Kv4.3 alongside Kv4.2 and Kv1.4 as distinct IA components.\",\n      \"evidence\": \"Co-IP/FRET and patch clamp in cardiomyocytes; single/double knockout mice with cortical neuron patch clamp\",\n      \"pmids\": [\"21148163\", \"20371829\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry of CaMKII sequestration in vivo not quantified\", \"Relative neuronal subunit contributions vary by cell type\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"The disease genetics of KCND3 were established; loss-of-function mutations cause SCA19/22 via ER retention and protein instability, while distinct gain-of-function mutations enhance Ito to cause Brugada syndrome and arrhythmias.\",\n      \"evidence\": \"Exome/Sanger sequencing, heterologous expression with localization and patch clamp, autopsy immunohistochemistry, and AP simulation\",\n      \"pmids\": [\"23280837\", \"23280838\", \"21349352\", \"22023388\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genotype-phenotype correlations across mutation spectrum incomplete\", \"Mechanism of ER quality-control recognition not defined\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"How loss-of-function mutants affect wild-type channels was unresolved; SCA19/22 mutants exert dominant-negative suppression of WT Kv4.3 trafficking and gating, with KChIP2 partially rescuing, and a voltage-sensor RVF duplication shows extra S4 charge profoundly impairs gating.\",\n      \"evidence\": \"Mutant/WT co-expression with surface expression and patch clamp plus KChIP2 rescue; exome sequencing with electrophysiology\",\n      \"pmids\": [\"25854634\", \"26189493\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo dominant-negative penetrance in patients not quantified\", \"Whether KChIP2 rescue is therapeutically achievable unknown\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Endogenous and pharmacological modulators of Kv4.3 were identified; SEMA3A acts as a direct protein inhibitor whose disease mutations cause Kv4.3 gain-of-function, and NS5806 enhances current via Ca2+-dependent KChIP3 binding.\",\n      \"evidence\": \"Co-IP, domain-disruption mutagenesis, iPSC-CM assays, and biophysical binding (ITC/fluorescence) with mutagenesis\",\n      \"pmids\": [\"24963029\", \"25228688\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological setting of SEMA3A-Kv4.3 regulation not fully defined\", \"In vivo efficacy of small-molecule modulators not established\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Translating Kv4.3 mechanism to precision therapy was the goal; patient-derived and isogenic iPSC-CM models confirmed gain-of-function mutations and demonstrated that channel blockers (acacetin, quinidine) normalize Ito and the action potential notch.\",\n      \"evidence\": \"Mutagenesis, heterologous and patient/isogenic iPSC-CM patch clamp and multielectrode array with pharmacology\",\n      \"pmids\": [\"35861988\", \"31173922\", \"23400760\", \"29313436\", \"31293010\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Clinical efficacy of these blockers across mutation classes untested\", \"Long-term safety of Ito-targeted therapy unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the multiple, often opposing regulatory inputs (phosphorylation, subunit composition, receptor coupling, transcriptional and post-transcriptional control) are integrated to set Kv4.3 surface density and gating in specific cardiac and neuronal cell types in vivo remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified quantitative model of complex assembly and regulation\", \"Cell-type-specific subunit/regulator combinations incompletely mapped\", \"In vivo therapeutic targeting not validated\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 2, 4]},\n      {\"term_id\": \"GO:0005216\", \"supporting_discovery_ids\": [0, 2]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 4, 38]},\n      {\"term_id\": \"GO:0140313\", \"supporting_discovery_ids\": [28]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [8, 12, 28, 32]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [32, 33]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-397014\", \"supporting_discovery_ids\": [4, 14]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [19, 29, 42]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [12, 16, 22, 28]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [31, 32, 33, 34]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [6, 40, 23]}\n    ],\n    \"complexes\": [\n      \"Kv4.3-KChIP2 channel complex\",\n      \"Kv4.3-KChIP-DPP6/DPPX native cardiac Ito complex\",\n      \"Kv4.3-AT1R complex\",\n      \"Kv4.3-CaMKII membrane complex\"\n    ],\n    \"partners\": [\n      \"KCNIP2\",\n      \"DPP6\",\n      \"DPP10\",\n      \"KCNE2\",\n      \"KCNAB2\",\n      \"AGTR1\",\n      \"CAMK2\",\n      \"SEMA3A\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}